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Summary
Shikimate dehydrogenase (SKDH) catalyses the fourth step of the biosynthetic shikimate 
pathway, the reversible reduction of 3-dehydroshikimate to shikimate. This Thesis 
describes the work leading to the identificaton of three active-site residues in E. coli 
SKDH.
Group specific chemical modification with trinitrobenzene sulfonic acid (TNBS) and kinetic 
analyses indicated the presence of an essential lysine residue at the active-site. Electrospray 
mass spectrometry (ESMS) revealed that three lysine residues were modified by TNBS, 
and in the presence of substrate and coenzyme two were protected from modification. 
HPLC mass spectrometry (LCMS) identified the three modified residues as Lys-15, Lys- 
65 and Lys-217/219. In the presence of substrate and coenzyme Lys-65 was completely 
protected and Lys-15 was partially protected from modification. Sequence comparison with 
other known SKDH sequences allowed the identification of Lys-65 as the essential lysine 
residue. Experiments with methyl shikimate have provided evidence for a role for Lys-65 
in substrate binding.
Arg-154 was identified as a component of the coenzyme (NADP+) binding site by group 
specific chemical modification with phenylglyoxal (PGO). Characterisation of PGO 
modified SKDH by ESMS showed that a PGO modified arginine residue could have either 
a 1:1 or 2:1 stoichiometry. Protection experiments suggest that Arg-154 interacts with the 
2' phosphate group of the adenosine moiety of the coenzyme.
Chemical modification with the group specific reagent diethylpyrocarbonate (DEPC) and 
kinetic analyses indicated the presence of an active-site histidine. Characterisation of DEPC 
modified SKDH by ESMS showed that in the presence of substrate and coenzyme two 
histidine residues were protected from DEPC modification. Differential peptide mapping 
using reverse phase HPLC identified the two protected residues as His-13 and His-253.
xiii
, , :
Sequence comparison with other SKDH sequences identified His-13 as the essential 
histidine. pH-dependence studies indicated a role for His-13 as a general acid/base in the 
catalytic reaction of SKDH.
As a preliminary step towards solving the three dimensional structure of SKDH small 
crystals have been obtained.
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Fig. 1.1 The shikimate pathway
1.1 The shikimate pathway
1.1.1 A general introduction
In plants and in micro-organisms, the biosynthesis of all the aromatic 
compounds involved in primary metabolism proceeds by way of the shikimate pathway 
(Haslam, 1974; Weiss and Edwards, 1980; Conn, 1986; Bentley, 1990; Haslam, 1993). 
The pathway is named after the first isolated intermediate; shikimic acid from the fruit of the 
plant Illicium religiosum of which the Japanese name is shikimi-no-ki (Eykmann, 1885). 
Eykmann's investigations coupled with the work of Karrer and Link (1927), Fischer and 
Dangschat (1932, 1934) and Freudenberg et a l (1940) led to the elucidation of the 
structure and stereochemistry of shikimic acid. However, the complete pathway was 
elucidated only after the isolation and characterisation of pathway intermediates from 
mutant micro-organisms by Davis, Weiss, Sprinson and Gibson more than 30 years ago 
(Davis, 1955; Levin and Sprinson, 1964; Gibson and Pittard, 1968).
Oxidation of glucose by glycolytic and pentose phosphate pathways yields 
phosphoenolpyruvate (PEP) and erythrose 4-phosphate (E4-P) respectively, the starting 
materials of shikimate pathway. The seven discrete enzymatic steps of the pathway begin 
with the condensation of these two products and proceeds via shikimate to chorismate 
which is the common precursor of all the aromatic amino acids and many other important 
compounds such as p-amino benzoic acid, ubiquinone and vitamin K (Haslam, 1974; 
Weiss and Edwards, 1980; Bentley, 1990; Haslam, 1993). The pathway is of particular 
importance in plants since it provides the precursors for the important structural polymer 
lignin, the flavinoids and secondary metabolites such as phenols and alkaloids (Coggins, 
1989). It had been estimated that up to 35% of the dry weight of higher plants is generated 
via shikimate pathway (Boudet et a l, 1985), thus a substantial proportion of carbon fixed 
by plants is channelled through the shikimate pathway.
Chorismate was considered to be the only branch point until recently, but it 
is now obvious that many of the pathway intermediates function as branch points (Bentley, 
1990; Haslam, 1993). Thus, a branch originating from the first intermediate of the
1
__
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pathway, 3-deoxy-D-arabino-heptulosonate 7-phosphate is involved in the biosynthesis of 
3-amino-5-hydroxybenzoate the proximate precursor of the m-C^N unit of ansamysin 
antibiotics (Kim et a l, 1992), while another branch originating from shikimate is found to 
be involved in the biosynthesis of the cyclohexanecarboxylate moiety of ansatrienin and the 
co-cyclohexyl fatty acids (Casati et a l, 1987; Moore and Floss, 1994).
The shikimate pathway is studied for two main reasons:-
(a) Enzymes of the shikimate pathway are potential targets for herbicides and anti-microbial 
agents. Mammals lack the capacity for aromatic biosynthesis and depend on their dietary 
intake for nutritionally essential amino acids, vitamins and cofactors produced by this 
pathway. Thus, inhibitors of the enzymes of this pathway should prove to be harmless to 
mammals and are potential targets for herbicides and anti-microbial agents (Coggins,
1989). A detailed knowledge of the chemistry of the individual enzymes of the pathway 
may lead to the design of such inhibitors. Already, the herbicide glyphosate (active 
component of the weed killer Roundup) which is an inhibitor of the shikimate pathway 
enzyme EPSP synthase has a widespread application in agriculture (Amrhein et a l, 1980; 
Steinrucken and Amrhein, 1980; Boocock and Coggins, 1983; Kishore and Shah, 1988). 
The pathway has also attracted attention as a target for antimicrobials against the fungus 
Pneumocystis carinii, which is the principal cause of fatal pneumonia in AIDS patients in 
Europe and in USA (Banerji et a l, 1993) and also effects malnourished children (Pixley et 
a l,  1991). Recently (6S)-6-fluoro-shikimic acid, an analogue of shikimic acid was 
reported as a potential antibacterial agent for the use in human medicine (Davies et a l, 
1994; Ewart et a l, 1995). Although the precise enzymatic target for this compound has not 
been confirmed this report demonstrates the vulnerability of this part of the aromatic 
biosynthetic pathway to potential attack by rationally designed compounds (Davies et a l, 
1994).
_____  ___  ________
(b) The shikimate pathway is a source of important secondary metabolites;
A host of important secondary metabolites such as antibiotics, mycotoxins, phenols and 
alkaloids are biosynthesised from shikimate-derived precursors. Genetic manipulation of 
the relevant biosynthetic steps may lead to the overproduction of some of these 
commercially important secondary metabolites.
1.1.2 Organisation of the shikimate pathway enzymes
Gene fusion and multifunctional enzymes emerged as a result of increasing 
complexity of the cell throughout evolution (Haslam, 1993). The shikimate pathway is an 
example of such an evolutionary modification in the organisation of enzymes. The seven 
enzymes catalysing the reaction sequence leading to the formation of chorismate are 
structurally and mechanistically similar in all organisms capable of aromatic biosynthesis, 
but their supramolecular organisation show considerable variation between species.
In Escherichia coli (and in other bacteria) the seven enzymes of the 
prechorismate pathway are monofunctional enzymes (Berlyn and Giles, 1969) and their 
genes are scattered throughout the genome (Pittard and Wallace; 1966). In fungi ,the 
enzymes catalysing the five consecutive steps involved in the conversion of DAHP to 
EPSP reside on a single pentafunctional polypeptide known as AROM, which is encoded 
by a single gene (Ahmed and Giles, 1969). The existence of a pentafunctional AROM 
protein has been demonstrated in Neurospora crassa (Lumsden and Coggins, 1977; 
Gaertner and Cole, 1977), Schizosaccharomyces pombe (Strauss, 1979) and Bug Lena. 
gracilis (Patel and Giles, 1979). The AROM encoding genes have been cloned and 
characterised from Aspergillus nidulans ( Charles et a l , 1986), Saccharomyces cerevisiae 
(Duncan et a l, 1987) and recently from Pneumocystis carinii (Banerji et a l, 1993). In 
plants the enzymes dehydroquinase and shikimate dehydrogenase which carry out two 
consecutive steps in the pathway are found as a bifunctional polypeptide whilst the other 
five enzymes of the pathway are monofunctional (Policy, 1978; Koshiba, 1979; Mousdale 
et a l, 1987), This bifunctional polypeptide has been cloned and characterised from Pisum 
sativum (Deka et a l, 1994) and Nicotiana tabacum (Bonner and Jensen, 1994). This
organisation of shüdmate pathway enzymes is illustrated in the schematic representation 
shown in Fig. 1.2.
The amino acid sequences of the AROM proteins studied to date are highly 
homologous with the monofunctional Escherichia coli counterparts and the most likely 
explanation for the origin of the gene encoding AROM is that it has evolved by the fusion 
of ancestral monofunctional genes like those found in E. coli (Hawkins, 1987). Studies on 
the Aspergillus nidulans AROM has shown that it is made up of two regions which can 
fold and function independently; the N-terminus containing dehydroquinate synthase and 
EPSP synthase domains and the C-terminus specifying shikimate kinase, dehydroquinase 
and shikimate dehydrogenase domains (Hawkins and Smith, 1991). In studies leading to 
the characterisation of the constituent domains of AROM in A. nidulans it has been shown 
that the EPSP domain is enzymatically active only when it is covalently linked to 
dehydroquinate synthase domain, suggesting that certain enzyme activities are stabilised by 
interactions between individual domains (Moore and Hawkins, 1993). However, more 
recent work on dehydroquinase and dehydroquinate synthase domains from the same 
organism has shown that they retain efficient catalytic activity in the monofunctional state 
(Hawkins et a l, 1993; Moore et a l, 1994). Characterisation of shikimate dehydrogenase 
and shikimate kinase domains have shown that they are not active as monofunctional 
domains, but are active as bifunctional proteins in combination with the 3-dehydroquinase 
domain (H. Lamb et a l , 1995/ manuscript submitted for publication).
1.1.3 Individual enzymes of the shikimate pathway
Detailed studies on the individual enzymes of the shikimate pathway had 
been hampered until recently, principally because the enzymes are present in low levels 
especially in plants and are difficult to purify, and secondly and importantly the substrates 
and coupling enzymes required for assays were not readily available (Coggins, 1989; 
Bentley, 1990; Haslam, 1993). However with the advances in recombinant DNA 
technology, all seven genes encoding Escherichia coli shikimate pathway enzymes have 
been cloned, overexpressed and sequenced (Coggins, 1989 and references cited therein;
I
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Fig. 1.2 Organisation of enzymes on the shikimate pathway
Bentley, 1990). As a result the enzymes are available in milligram quantities and studies of 
the enzyraology of shikimate pathway has become an active area of biochemical research. 
The progress made over the recent years on each individual enzyme in the prechorismate 
part of the pathway is summ^sed below.
1.1.3.1 3-Deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthase
DAHP synthase (EC 4.1.2.15) catalyses the first committed step in the 
shikimate pathway; the condensation of phosphoenolpyruvate (PEP) and erythrose 4- 
phosphate (E4P) to form DAHP (Step I, Fig 1.1). DAHP synthase is a regulatory enzyme 
and is known to posses the largest number of allosteric regulatory patterns described for 
any one protein (Bentley, 1990; Haslam, 1993). Four regulatory forms of this enzyme are 
known;
(1) DAHP synthase-O AUostericaUy insensitive
(2) DAHP synthase-X Inhibited by X
(3) DAHP synthase-X(Y) Inhibited by both X and Y, with X being more
powerful
(4) DAHP synthase-M^+ Stimulated by divalent metal,
The precise mechanism of DAHP synthase reaction is not fully understood 
(Haslam, 1993). Reaction of E4P with PEP in which the enol oxygen atom was labelled 
with isotope 1^0 has shown that the reaction proceeds with a C-O cleavage rather than a 
P-0 cleavage since the isotopically labelled oxygen atom has been recovered in the 
inorganic orthophosphate released in the reaction (DeLeo and Sprinson, 1968; Nagano and 
Zalkin, 1970). A mechanism for the mode of action has been proposed in which an 
enzymic cysteinyl residue is involved (Ganem, 1978) as many DAHP synthases have been 
shown to be susceptible to inhibition by thiol modifying reagents (Staub and Denes, 1969; 
Huisman and Kosuge, 1974; Sugimoto and Shiio, 1980; Ray and Bauerle, 1991). In this 
mechanism the enzyme bound enolpyruvyl group condenses with E4P leading to the 
formation of DAHP and the release of free enzyme. This mechanism is consistent with the
required C-O cleavage noted earlier.
In E.coli three isozymes of DAHP synthase are known (Doy and Brown, 
1965) which shows a high degree (41%) of sequence homology suggesting a common 
evolutionary origin (Bentley, 1990). These isozymes display an inhibition pattern in which 
each isozyme is feedback inhibited and repressed by one of the aromatic amino acids, 
providing the E. coli cell with the ability to regulate the synthetic rates in response to 
exogenous availability of aromatic amino acids (Bentley, 1990; Haslam, 1993). Thus, 
modulation of DAHP synthase isozymes is a major quantitative mechanism to control the 
flow of carbon into the shikimate pathway (Ogino eta l, 1982).
The existence of DAHP isozymes in many micro-organisms and their 
regulation through various types of feedback inhibition have been reported (Bentley,
1990). A different form of DAHP synthase is found in Bacillus subtilis , where it exists as 
a bifunctional protein with chorismate mutase, and is feedback inhibited mainly by 
prephenate and to a lesser extent by chorismate (Hasan and Nester, 1978).
In plants two isozymes of DAHP synthase are found in general, which are 
stimulated by Co+^ or Mn+^ (Rubin and Jensen, 1985; Ganson et a l, 1986, Morris et 
a/., 1989). In some cases reported aromatic amino acids have an inhibitory effect on plant 
DAHP isozymes, whereas in some other cases they exert an activation effect (Suzich et 
a/.,1985; Huisman and Kosuge, 1974; Graziana and Boudet, 1980; Pinto et a l, 1986). 
Thus, the contradictory observations of inhibition and regulatory patterns have not yet 
allowed general conclusions to be drawn for plant DAHP synthases. The important 
herbicide glyphosate is reported to inhibit the DAHP synthase-Co+^ from mung bean and 
from Nicotiana silvestris (Rubin et a l, 1982; Ganson and Jensen, 1988). More recent 
work on the plant DAHP synthase isozymes have shown that their synthesis is influenced 
by growth and environmental factors (Henstrand et al, 1992; Sharma et al, 1993).
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1.1.3.2 3-Dehydroquinate synthase
3-Dehydroquinate (DHQ) synthase (EC 4.6.1.3) catalyses the ring closure 
of DAHP to form the first alicyclic intermediate of the pathway (Step II, Fig 1.1). The 
mechanism of 3-dehydroquinate synthase involves considerable chemistry; oxidation, g- 
elimination, reduction and intramolecular aldol condensation (Bartlett and Satake, 1988).
The possible overall mechanism of DHQ synthase has been elucidated by 
using substrate analogues (Bender et a l, 1989; Widlanski eta l, 1989a). Work done using 
synthetic 2-deoxy DAHP had shown that DHQ synthase catalyses only the first three steps 
of the normal reaction; oxidation, elimination and reduction ( Bartlett and Satake, 1988; 
Widlanski et a l,  1989b). Thus, the final step of aldol cyclysation appears to be non- 
enzymatic. NAD+ is essential for DHQ synthase activity and is involved in the oxidation 
and reduction of the hydroxyl group at C-5 position (Srinivasan et a l, 1963). The 
mechanism involves a base for deprotonation at C-6, which leads to subsequent elimination 
of phosphate. On the basis of work with carbacyclic phosphonate analogues of DAHP it 
had been shown that an enzyme group is not required and instead, the phosphate group of 
DAHP itself functions as the base (Widlanski et a l, 1989b). However, the positioning of 
the phosphate group appears to be crucial for proton abstraction. It had also been shown 
that the pyranose form of DAHP is involved in the mechanism (Widlanski et a l, 1989a).
3-Dehydroquinate synthase has been purified to homogeneity from E. coli 
(Frost et a l, 1984; Millar and Coggins, 1986) and Phaseolus mungo (Yamamoto, 1980) 
and appear to be dependent on a divalent metal ion for activity. Interestingly, DHQ 
synthase activity from AROM protein of Neurospora crassa also has a Zn+^ requirement 
(Lambert et a l, 1985). In B, subtilis the enzyme is associated with chorismate synthase 
and a flavin reductase in a multienzyme complex (Hasan and Nester, 1978). E. coli 
enzyme has a monomeric structure (Frost et a l, 1984; Millar and Coggins, 1986) whilst 
the plant enzyme from pea seedlings has a dimeric structure (Pompliano et a l, 1989).
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1.1.3.3 3-Dehydroquinate dehydratase (3-Dehydroquinase)
3-Dehydroquinase (DHQase) (EC 4.2.1.10) catalyses the third step of the 
shikimate pathway; the conversion of 3-dehydroquinate to 3-dehydroshikimate (Step III, 
Fig 1.1). The syn elimination of a water molecule from 3-dehydroquinate introduces the 
first double bond into the aromatic ring system (Turner et a i, 1975). This reaction is 
common to two metabolic pathways; the biosynthetic shikimate pathway and the catabolic 
quinate pathway. Thus, two types of DHQases are found, namely type I and type II 
involved in shikimate and quinate pathways respectively. The two classes of enzymes were 
found to be unrelated at the level of primary structure (Garbe et a l, 1991).
The biosynthetic type I enzyme has been purified and characterised from an 
overproducing strain of E. coli (Chaudhuri et a l, 1986), The mechanism of action of type 
I DHQase from E, coli has been studied in detail. The syn elimination of elements of water 
proceeds via a Schiff’s base intermediate formed by the reaction of substrate carbonyl 
group with the €-amino group of an active site lysine followed by the abstraction of a 
proton by a general base (Walsh, 1979). In E. coli the active site lysine has been identified 
as Lys-170 (Chaudhuri, 1991) and His-143 as the general base involved in deprotonation 
(Deka et a l, 1992). Furthermore, Met-23 and Met-205 has been identified as likely active 
site residues but their role in catalysis has not been established (Kleanthous et a l, 1990; 
Kleanthous and Coggins, 1990). The type I enzymes from Salmonella typhi (Servos et al,
1991), A. nidulans (Charles et a l, 1985) and N. crassa (Smith and Coggins, 1983) have 
been purified and the active site lysine involved in the Schiff s base formation has been 
identified in N.crassa (Chaudhuri et a l, 1991).
The type II enzyme is catabolic and quinate inducible. It has been 
characterised from A.nidulans ( Da Silva et a l, 1986), N. crassa (Hawkins et a l, 1982) 
and from the bacteria Streptomyces coelicolor (White et a l, 1990) and Mycobacterium 
tuberculosis (Garbe et a l, 199J). A dual function type II enzyme has been isolated from 
Amycolatropsis methanolica which is involved in both quinate catabolism and biosynthesis 
of aromatic amino acids (Euverink et a l , 1992). Unlike type I enzymes the type n  enzymes 
do not work through a Schiffs base intermediate (Kleanthous et a l, 1992). More
_______________
recently, work done on the active site of type II DHQases has resulted in the identification 
of an active site arginine residue which is thought to be involved in substrate binding (Krell 
e ta l,  1995).
Type I and type n  DHQases have different biophysical and mechanistic properties. 
Type I enzymes were found to be heat labile and dimeric in structure whilst type II enzymes 
were heat stable and dodecameric in structure (Kleanthous et a l, 1992). The elimination of 
water proceeds with opposite stereochemistries in type I and type II enzymes; syn and anti 
respectively (Schneier et a l, 1993). Crystallisation studies of DHQases have progressed 
over the recent years. Both a type I and a type II enzyme have been crystallised (from 
S. typhi and M. tuberculosis respectively) and the space groups determined (Boys et al, 
1992; Gourley e ta l,  1994).
1.1.3.4 Shikimate dehydrogenase
This is the major topic of this thesis and is discussed in section 1.2.2.
1.1.3.5 Shikimate kinase
Shikimate kinase (EC 2.7.1.71) catalyses the fifth step of the shikimate
pathway, the phosphate transfer from ATP to the C-3 hydroxyl group of shikimate (Step 
lyV, Fig. 1.1). Unusua^for an enzyme in the middle of a metabolic pathway two isozymic 
forms of shikimate kinases have been described in E, coli and S. typhi (Ely and Pittard, 
1979; Berlyn and Giles, 1969).
In E. coli, shikimate kinase H, encoded by the aro L gene is under specific 
control of tyrR regulator gene and is repressed by tyrosine or tryptophan (Ely and Pittard, 
1979; DeFeyter et a l, 1986). Specific modulation of gene expression usually affects genes 
encoding the first enzymes in a pathway, and in the example of the shikimate pathway in 
E.coli only three DAHP synthases and shikimate kinase n  are subjected to such regulation. 
This led to the hypothesis that an unrecognised metabolic pathway branches at shikimate 
(Pittard, 1987). Recent work has provided evidence for the existence of such biosynthetic 
branches (Moore and Floss, 1994).
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The gene encoding shikimate kinase II has been cloned , sequenced and 
overexpressed from E. coli and was found to be a monomer (Millar et a l, 1986; DeFeyter 
and Pittard, 1986a). Recently, the gene encoding shikimate kinase I from E. coli has also 
been identified {aro K) (Lobner-Olesen and Marinus, 1992). Kinetic analysis of the E. coli 
isozymes showed that the K,^ for shikimate of shikimate kinase I is 100 fold higher than 
that for shikimate kinase n  (DeFeyter and Pittard, 1986b). A likely explanation for this is 
that shikimate kinase II is the one which normally functions in aromatic biosynthesis in the 
E. coli cell and shikimate kinase I functions only when intracellular shikimate levels exceed 
a particular threshold (DeFeyter and Pittard, 1986b; Haslam, 1993), or possibly the 
enzyme has a completely different metabolic role. The primary structure of both enzymes 
contain a region homologous with other known kinases which is likely to be a part of the 
ATP binding domain (Millar e ta l,  1986; Lobner-Olesen and Marinus, 1992).
In B, subtilis a single shikimate kinase exists as a component of a 
trifunctional enzyme complex with DAHP synthase and chorismate mutase activities 
(Nakatsukasa and Nester, 1972; Huang et al, 1975),Dissociation of shikimate kinase from 
this complex results in the loss of activity, A single shikimate kinase isolated from tomato 
shows homology with bacterial enzymes and contains an ATP binding site (Schimd et a l ,
1992).
1.1.3.6 5-Enolpyruvyl-shikimate 3-phosphate (EPSP) synthase
EPSP synthase (EC 2.5.1.19) catalyses the formation of EPSP from 
shikimate 3-phosphate and PEP (Step VI, Fig 1.1). This reaction is of considerable 
importance since EPSP synthase is the major target for inhibition of the broad spectrum 
herbicide glyphosate (the active component of the weed killer Roundup) (Steinrucken and 
Amrhein, 1980; Boocock and Coggins, 1983). Thus, this enzyme remains the most 
intensively investigated among the shikimate pathway enzymes (Bentley, 1990).
The genes encoding EPSP synthases have been isolated and sequenced 
from bacteria (Duncan et a l, 1984a,b; Stalker et a l, 1985), fungi (Duncan et a l, 1987; 
Charles et a l, 1986) and from a range of plants (Casser et a l, 1988; Granger, 1989; Wang
1 1
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et a l ,1991). Comparison of EPSP synthase sequence data from bacterial (E. co li, S. 
typhi ), fungal (A. nidulans, S. cerevisiae) and plant species {Petunia hybrida, tomato) 
showed a consistent pattern; the sequence homology observed between the bacterial and 
plant enzymes was much greater (approximately 54%) than that observed between the 
fungal and plant or the fungal and bacterial sequences (approximately 38%) suggesting a 
lat^divergence of the plant and bacterial EPSP synthase enzymes than the plant and fungal 
enzymes (Casser et a l, 1988).
The agronomic importance of EPSP synthase has led to the detailed 
investigation of the mechanism of action , The 'Sprinson mechanism' proposed two 
decades ago, involves the transfer of a carboxyvinyl moiety from PEP to the hydroxyl 
group at C-5 of shikimate 3-phosphate and proceeds via a tetrahedral intermediate (Levin 
and Sprinson, 1960; Levin and Sprinson, 1964). Research done since then, has provided 
evidence to validate the 'Sprinson mechanism'. Isotope labelling studies have shown that 
the C-O bond of PEP is cleaved (rather than the 0-P bond) in the elimination of phosphate 
(Bondinell et a l, 1971) and kinetic experiments have revealed that EPSP synthase 
functions through an ordered mechanism with shikimate 3-phosphate binding first, 
followed by PEP (Boocock and Coggins, 1983; Anderson et a l, 1988a). More recently, 
the isolation and characterisation of the tetrahedral intermediate has provided conclusive 
evidence for the 'Sprinson mechanism’ (Anderson et a l, 1988b; Leo et a l, 1990).
The active site of EPSP synthase has been studied by group specific 
chemical modification and a large number of active site residues involved in catalysis or 
binding have been identified. These include; arginine (Arg-28 and Arg-131 for Petunia 
hybrida) (Padgette e ta l,  1988a), glutamate (Glu-418 forE. coli) (Huynh, 1988), cysteine 
(Cys-408 for E. coli) (Padgette et a l, 1988b), lysine (Lys-22 for E. coli and Lys-23 for 
P.hybrida) (Huynh et a l, 1988a,b) and histidine (His-385 for E, coli) (Huynh, 1993). 
Protection experiments have shown that the essential histidine and glutamate residues are 
located at or near the glyphosate binding site (Huynh, 1988; 1993). The cysteine residue 
was found to be not essential for catalysis or binding, however its protection by shikimate 
3-phosphate or glyphosate from chemical modification has been attributed to its proximity
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to the active site. Further confirmation of these data must await the determination of the 
three dimensional structure of the enzyme.
The mode of inhibition of EPSP synthase by glyphosate is not clearly 
understood. It has been shown that glyphosate is a competitive inhibitor of PEP (Boocock 
and Coggins, 1983). The inhibition is strongly pH dependent (Steinrucken and Amrhein, 
1984; Rubin et a l, 1984), with a striking increase between pH 6.0-8.0. Based on this 
evidence and the pK values of the various ionizable groups of glyphosate, it was suggested 
that the ionised form of glyphosate is the kinetically active form and that glyphosate acts as 
a transition state analogue of PEP (Anton et a l, 1983; Steinrucken and Amrhein, 1984). 
The definition of a single kinetically competent intermediate in the EPSP synthase reaction 
has prompted the design of new inhibitors. Two phosphonate analogues of the tetrahedral 
intermediate has been evaluated as inhibitors of EPSP synthase from P. hybrida (Alberg 
and Bartlett, 1989). Recently, it has been shown that the 3-phosphate group contributes 
significantly to substrate and inhibitor recognition at the shikimate 3-phosphate site (Miller 
et a l, 1993) and this work has been followed by the synthesis of potential inhibitors which 
are aromatic analogues of shikimate-3-phosphate and EPSP containing replacements of the 
3-phosphate group (Miller et a l,  1994). Moreover, a glyphosate analogue namely, N- 
amino glyphosate has been synthesised recently and is reported as the first successful 
modification of the glyphosate skeleton which exhibits inhibitor properties comparable to 
glyphosate (Knowles e ta l,  1993).
1.1.3.7 Chorismate synthase
The seventh and the final step in the common part of shikimate pathway is 
catalysed by the enzyme chorismate synthase (EC 4.6.1.4) (Step VII, Fig. 1.1). This 
enzyme introduces the second of the three double bonds which are necessary for formation 
of the aromatic ring. The reaction requires a reduced flavin cofactor although no net overall 
change in the redox state of the substrate is observed.
Chorismate synthase has been characterised from three microbial sources; 
E. coli (Morell et a l, 1967; White et a l, 1988), B. subtilis (Hasan and Nester, 1978) and
13
__________ ___ _______  ______
N. crassa (Welch et a l, 1974; White et a l, 1988) and from plant sources; P. sativum 
(Mousdale and Coggins, 1986), Corydalis sempervirens (Schaller et a i, 1990) and 
Euglena gracilis (Schaller et a l, 1991). Recently two isozymic forms of chorismate 
synthase have been identified in tomato (Gorlach et al, 1993). The enzymes thus far 
described display marked differences in their ability to generate the reduced flavin cofactor 
necessary for catalysis. In N. crassa, B. subtilis and E. gracilis chorismate synthase is 
bifunctional and is associated with a flavin reductase activity (diaphorase activity) which 
can generate the reduced flavin cofactor via the oxidation of nicotinamide nucleotide under 
aerobic conditions. In contrast, chorismate synthase from E. co li , P. sativum and 
C. sempervirens is monofunctional and does not contain the diaphorase avtivity. Thus, 
reaction proceeds only when reduced flavin is supplied exogenously under anaerobic 
conditions (Morell et a l, 1967; Gaertner, 1987). Both E. coli and N. crassa enzymes are 
tetrameric in structure (White et a l, 1988) and the deduced subunit Mj^ is 38,183 and 
50,000 respectively. The smaller subunit size of E. coli may reflect a 'missing' diaphorase 
domain.
The need for a reduced flavin cofactor although the conversion of EPSP to 
chorismate is redox neutral appears unusual. This has attracted attention to the mechanism 
of action of chorismate synthase. Several distinctive mechanisms have been proposed, but 
none of these addresses the question of the role of reduced flavin in the catalytic process. 
However, the reaction is known to proceed with anti stereochemistry and involves the 
removal of the C-6 pro-R  hydrogen atom and the loss of phosphate group in a 1,4 
elimination process (Floss et a l, 1972; Hill and Newkome, 1969). Recent experiments 
have demonstrated that there is a spectral change associated with the flavin during the 
catalytic reaction (Ramjee et a l, 1991) and that an enzyme bound flavin mononucleotide 
free radical is formed stoichiometrically in the presence of the substrate analogue 6R-6- 
fluro EPSP (Ramjee et a l, 1992). Based on the observation of a secondary tritium isotope 
effect for the reaction catalysed by N. crassa chorismate synthase, it had been suggested 
that the mechanism probably involves a cleavage of the C6-H and C3-0 bonds in distinct 
but partially rate determining steps (Balasubramanian eta l, 1995).
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1.1.4 The shikimate pathway as a source of secondary metabolites
A secondary metabolite is defined as a substance that occur in a limited 
number of organisms, not universally, and the function of which, if known, is not that of 
an intermediate in metabolism (Weiss and Edwards, 1980). These metabolites are a 
measure of the fitness of the organism to survive and may be involved in its welfare, life 
and development (Haslam, 1993). In micro-organisms and plants a host of important 
secondary metabolites such as antibiotics and alkaloids are derived wholly or partially via 
the shikimate pathway. They are of commercial importance and have a widespread 
application in medicine, agriculture and food sciences. A brief description of these two 
groups of secondary metabolites are given below.
1.1.4.1 Antibiotics
An antibiotic is a chemical substance produced by a micro-organism, which 
in low concentration inhibits the growth of other micro-organisms. Traditionally antibiotics 
have been produced by fermentation, but advances in synthetic chemistry have led to some 
antibiotics being wholly or partially chemically synthesised.
In certain micro-organisms a range of antibiotics are biosynthesised from 
precursors derived from the shikimate pathway. During normal growth the biosynthesis of 
aromatic amino acids would not be regarded as a major metabolic route considering the low 
abundance of such amino acids in proteins, but following cessation of growth and initiation 
of aromatic containing antibiotic biosynthesis an enormous metabolic load would need to be 
channelled through the shikimate pathway. A few examples of shikimate derived antibiotics 
are summarised below.
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(a) Ansamycins
This class of antibiotics are produced by different micro-organisms 
including Streptomyces and Norcardia sp. Ansamycins are characterised by a cyclic 
structure consisting of an aromatic group (benzenoid or napthalenoid) and a polyketide 
derived aromatic chain that form a bridge between two non adjacent positions on the 
aromatic nucleus. All ansamycins contain a m-C-yN unit derived from 3-amino 
hydroxybenzoate, of which the amino analogue of DAHP is the ultimate precursor (Casati 
et a l, 1987; Kim et a l, 1992). Rifamycins are the only group of ansamycins commercially 
exploited. They are active against Gram positive bacteria and strongly inhibit RNA 
synthesis by inhibition of DNA dependent RNA polymerase. Rifampin is one of the most 
useful members of this group and is a major drug for the treatment of tuberculosis and 
leprosy.
(b) Chloramphenicol
Chloramphenicol is a metabolite if Streptomyces venezuelae and other 
Streptomyces sp. It is biosynthesised from chorismate via L-/7-amino-phenylalanine (L- 
PAPA) which is the proximate precursor (Dardenne et a l, 1975). It is an inhibitor of 
protein synthesis and exerts its action by inhibiting libosomal peptidyltransferase activity. 
Cloramphenicol is primarily used in the treatment of typhoid fever, bacterial meningitis and 
anaerobic infections.
(c) Phenazines
There are more than 50 phenazine pigments formed exclusively by bacteria 
(Byng and Turner, 1977; Turner and Messenger, 1986). Phenazines show antibiotic 
properties and an ability to intercalate with double stranded DNA. Recent studies have 
shown anthranilate to be the shikimate pathway intermediate from which the precursor 
molecule of phenazines, phenazine-1-6-dicarboxylate is derived (Essar et a l, 1990). 
Phenazines are active against Gram negative bacteria, fungi and actinomycetes.
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(d) Streptonigrin
Streptonigrin is an anticancer antibiotic produced by Sreptomyces flocculus. 
The biosynthetic pathway of streptonigrin is known in considerable detail. It is derived 
from L-tryptophan and 4-amino anthranilate, a modified shikimate pathway intermediate, 
which then condenses with a four carbon acid (probably oxaloacetate) derived from the 
tricarboxylic acid cycle (Erickson and Gould, 1987).
(e) Vancomycin
Vancomycin is a bactericidal peptide antibiotic active against many species 
of Gram-positive cocci. It is a heptapeptide and contains two units of |3- 
hydroxychlorotyrosine as structural components which are derived from L-tyrosine 
(Hammond et a l, 1982). It interferes with peptidoglycan biosynthesis by binding 
irreversibly to the acyl-D-alanyl-D-alanine terminus of the membrane bound peptidoglycan 
precursor. It is a valuable alternative therapy for serious infections caused by methicillin- 
resistant staphylococci, especially in patients allergic to the p-lactam agents. It is also the 
drug of choice for treatment of intestinal infections caused by Clostridium difficile.
1.1.4.2 Alkaloids
Alkaloids are basic, nitrogen containing compounds with complex 
molecular structures. The major source of alkaloids are higher plants but they also occur in 
micro-organisms, insects and animals. Alkaloids posses pharmacological activity ranging 
from extreme toxicity to valuable pharmaceuticals.
Morphine is an alkaloid of shikimate origin produced by the Papaver sp. It 
is an analgesic and is a major drug used in the treatment of deep-seated pain. The 
biosynthetic pathway of morphine is well characterised and the ultimate precursor is 3,4 
dihydroxyphenylalanine (DOPA) derived from L-tyrosine. Dopamine and 3,4 
dihydroxyphenylpyruvate, both derived from DOPA react to form norlaudanosoline 
carboxylic acid, the first alkaloid in the biosynthetic pathway, which through a series of 
chemical reactions is converted to morphine (Robinson, 1981).
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1.2 The family of pyridine nucleotide dependent dehydrogenases
1.2.1 A general introduction
In metabolic processes, nucleotides are involved in two classes of energy 
transfer mechanisms; the first class involves hydrolysis of high energy phosphate bonds in 
triphosphates such as ATP or GTP and the second class involves electron transfer through 
hydrogen atoms (redox) of bases such as nicotinamide and isoalloxazine. Pyridine 
nucleotides belong to the latter group and contain nicotinamide as NAD+ or as NADP+ 
which has an extra phosphate group at the 2' hydroxyl group of the adenosine moiety (Fig 
1.3). The oxidized forms NAD+ and NADP+, accept electrons in the foim of a hydride ion 
that binds covalently to the C4 atom of thé nicotinamide moiety, to give the reduced forms 
NADH and NADPH respectively. NADH is primarily used for the generation of ATP 
whereas NADPH is used almost exclusively in reductive biosynthesis.
The pyridine nucleotide coenzymes are employed by a large number of 
enzymes for the transfer of redox equivalents to various metabolites. The reactions 
catalysed by these enzymes include the reversible reduction of carbonyl bonds 
(dehydrogenases), Schiff bases or disulphide bonds (reductases) and aromatic carbon- 
oxygen bonds (hydroxylases). Among these, the dehydrogenases comprise the largest and 
best studied family.
Two groups of pyridine nucleotide dependent dehydrogenases can be 
identified. The enzymes of one group require a metal atom such as zinc or iron for activity 
whereas the other group do not contain any catalytically important metal atom (Aronson et 
a l,  1989; Neale et a l, 1986; Jornvall et a l, 1984). In both cases the substrate carbonyl 
group is reduced by the transfer of a hydride ion from NAD(P)H (Fisher et a l, 1953; 
Loewus e ta l,  1953). In many dehydrogenases including lactate dehydrogenase (LDH), 
malate dehydrogenase (MDH) and glyceraldehyde-3-phosphate dehydrogenase (G3PDH) 
the substrate carbonyl forms a hydrogen bond with a proton from an acid catalyst, thus 
polarising the carbonyl group and facilitating direct hydride transfer. In all three cases the 
acid catalyst involved in the mechanism is a histidine side chain (Adams et a l, 1973; 
Holbrook et a l, 1974; Moras et a l, 1975). However, in the presence of a catalytically
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Fig. 1.3 Structure of the oxidised form of nicotinamide adenine 
dinucleotide (NAD'*') and of nicotinamide adenine dinucleotide 
phosphate (NADP+). In NAD% R=H; in NADP+, RsPOj^
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important zinc ion as in the case of liver alcohol dehydrogenase (LADH), the zinc ion takes 
the place of the acid catalyst, in polarizing the substrate carbonyl to facilitate hydride 
transfer (Eklund et a l, 1982). The transfer of the hydride ion from NAD(P)H is 
stereospecific, and two classes of dehydrogenases can be identified depending on the 
stereospecificity (Westheimer e ta l,  1951; Fisher e ta l ,  1953). Class A dehydrogenases 
transfer the pro-R  hydrogen (e.g. LDH, isocitrate dehydrogenase) and class B 
dehydrogenases transfer the pro-S hydrogen (e.g. G3PDH, glutamate dehydrogenase),
‘ depending on which side of the nicotinamide ring faces the substrate. Furthermore, it has 
been observed that class A dehydrogenases catalyse the reduction of more reactive 
carbonyls, while class B is associated with the less reactive carbonyls (Fersht, 1985).
In many dehydrogenases the binding of substrate and coenzyme follow a 
compulsory order; the coenzyme binds first to the enzyme to form a binary complex 
followed by substrate binding to form a ternary complex. The molecular explanation for 
this is the binding of the coenzyme causes a conformational change that increases the 
affinity of the enzyme for the other substrate. A few examples of the many dehydrogenases 
which follow a compulsory order in binding are LDH (Winer and Schwert, 1958; Schwert 
e ta l ,  1967; Zewe and Fromm, 1965; Holbrook et a l,  1975), alcohol dehydrogenase 
(Dalziel, 1963; Wratten and Cleland, 1963; 1965), ribitol dehydrogenase (Fromm and 
Nelson, 1962), isocitrate dehydrogenase (Nimmo, 1986) and glucose-6-phosphate 
dehydrogenase (Olive et a l, 1971). It had been shown for LDH and LADH that the ternary 
complex does not accumulate in the steady state but is rapidly converted to the product 
ternary complex which then dissociates to the product and enzyme-coenzyme binary 
complex (Dalziel, 1975; Holbrook and Gutfreund, 1973).
Based on the concept of structure-function relationships, structural 
similarities among the members of the pyridine nucleotide dependent dehydrogenase family 
can be expected. The three dimensional structures of many dehydrogenases have been 
solved and based on the structures of LDH (Adams et a l, 1970; 1973), G3PDH (Buehner 
e ta l, 1973; 1974), MDH (Hill e ta l, 1972; Webb e ta l, 1973) and LADH (Branden eta l, 
1973; Eklund e ta l,  1974) certain generalisations concerning the structural features of the
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dehydrogenase family can be made. The polypeptide chains of these four dehydrogenases 
fold into two clearly separated domains; a catalytic domain and a nucleotide binding 
domain. The structures of the catalytic domains differ in each case, but the structures of the 
nucleotide binding domains are remarkably similar although there is no sequence 
homology. Moreover, the position of this domain within the polypeptide chain varies in the 
four dehydrogenases. Comparison of the structures of the nucleotide binding domains of 
LDH, G3PDH and LADH had shown that each domain consists of two roughly identical 
folds, each associated with a mono-nucleotide binding (Fig. 1.4) ( Rossmann e ta l, 1974; 
Ohlsson et a l, 1974). This fold is known as the 'Rossmann fold' and consists of three 
parallel P-strands connected by helices in a right handed cross-over fashion (Richardson, 
1976; 1977). The pyrophosphate group of the nucleotide binds in the central region of the 
domain at the N-terminal end of one of the connecting helices. The helix-dipole interacts 
favourably with the negatively charged pyrophosphate moiety and contributes significantly 
to the formation of nucleotide-enzyme complex (Hoi e ta l ,  1978). This pyrophosphate 
binding helix form a part of a compact pap  fold, and a characteristic fingerprint for the 
amino acid sequence of this fold had been deduced (Wierenga et a l, 1985). The PaP fold 
is common to many pyridine nucleotide binding enzymes (Rossman et a l, 1975) and 
comprises of a universally conserved G-X-G-X-X-G (where X is any amino acid) 
sequence which appears at the border between the first strand of a P-sheet and the a-helix 
allowing the formation of a tight turn (Wierenga et a l, 1985; 1986). Other conserved 
features of this finger print region are (1) a hydrophilic residue at the N-terminus of the first 
P-strand, (2) a hydrophobic core composed of six small residues, and (3) a negatively 
charged residue at the C-terminus of the second p-strand which forms a hydrogen bond 
with the 2’ hydroxyl group of the adenine ribose of NAD+ (Wierenga et a l, 1985). In 
NADP+ binding proteins this negatively charged residue has been replaced, presumably to 
accommodate the 2' phosphate group of adenine ribose (Wierenga et a l, 1985). It appears 
that this residue is an important means by which the dehydrogenases discriminate between 
NAD+ and NADP+ as coenzyme.
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Fig. 1.4 The dinucleotide-binding domain of lactate dehydrogenase. The 
pyrophosphate group of NAD+ binds in the central region of the domain at 
the N-terminal end of one of the connecting helices.
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1.2.2 Shikimate dehydrogenase
1.2.2.1 The reaction catalysed by shikimate dehydrogenase
COO"
OHO
COO"NADPH N A D P
OH
OH OH
Fig. 1.5 Shikimate dehydrogenase catalyses the reversible reduction of 3-dehydroshikimate to shikimate
Shikimate dehydrogenase (SKDH) (EC 1.1.1.25) catalyses the fourth step 
of the shikimate pathway; the reversible reduction of 3-dehydroshikimate to shikimate (Fig. 
1.5). It is an NADP+-specific dehydrogenase (Yaniv and Gilvarg, 1955) which exhibits 
'A'-type stereospecificity (Dansette and Azerad, 1974).
During the SKDH reaction, a proton is acquired by the carbonyl oxygen and 
the A~pro ~R hydrogen of the coenzyme (NADPH) is transferred as a hydride ion to the 
carbonyl carbon of the substrate. This proton can be considered most likely to be provided 
by a group capable of participating in hydrogen bonding and proton release/acceptance. In 
many pyridine nucleotide dependent dehydrogenases this role is fulfilled by a histidine 
residue (Price and. Stevens, 1989). It had been observed that E. coli SKDH could be 
rapidly inactivated by histidine specific reagent diethyl pyrocarbonate and the involvement 
of a histidine residue in the catalytic mechanism of SKDH has been proposed (R. Syme 
and J R. Coggins, unpublished data).
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Fig. 1.6 /  ' „dehydrogenase sequencesA dendogram representing sim ilarities between shikimate
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1.2.2.2 Sequence similarities of shikimate dehydrogenase domains
The amino acid sequences of SKDH domains haw been determined from A. 
nidulans (Charles et al., 1986), S.cerevisiae (Duncan et a i, 1987), E. coli (Anton and 
Coggins, 1988), P. carinii (Banerji et a l,  1993), P,sativum  (Deka et a l,  1994), N. 
tabacum  (Bonner and Jensen, 1994), Pseudomonas aeruginosa (Hungerer et al, 
EMBL/GenBank accession no. X85015) and Buchnera aphidicola (Rouhbakhsh, 
EMBL/GenBank accession no. U09230) and are now available for sequence comparison 
studies. Based on the similarity of sequence data, relationships between SKDH sequences 
from different organisms can be described. This is done by using GCG PileUp program 
(Devereux et a l, 1987) which creates a multiple sequence alignment from a group of 
related sequences using progressive, pairwise alignments. The two most similar sequences 
are aligned first producing a cluster followed by the alignment of the next most related 
sequence to this cluster or the next most related sequences to each other to produce another 
cluster. This is continued until all sequences have been included in a final pairwise 
alignment. A dendogram or a tree representing the clustering relationships between SKDH 
sequences are shown in Fig. 1.6. Accordingly, the two plant sequences (P. sativum and 
N. tobacum) appear to be the most closely related from all the SKDH sequences. Among 
the bacterial sequences, the E. coli sequence has more similarity with the P, aeruginosa 
sequence than with B. aphidicola sequence while and S. cerevisiae are closely
related among the fungal sequences.
1.2.2.3 E, coli Shikimate dehydrogenase
SKDH occurs in very low levels in bacteria and it had been partially purified 
from wild type E. coli by Yaniv and Gilvarg (1955). This work was followed by 
Chaudhuri and Coggins (1985) and the enzyme was purified more than 10,000 fold to 
achieve homogeneity. As a result a very low concentration of enzyme has been available 
and this had hampered the detailed study of this enzyme. However, the gene encoding 
E, coli SKDH (aro E) has now been cloned, sequenced and placed under the control of a 
powerful promoter to facilitate overexpression (Anton and Coggins, 1984, 1988). As a
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result milligram quantities of the enzyme can be readily obtained from 20g batches of 
E, coli cells (Chaudhuri et a i, 1987). This has opened the way for detailed studies on the 
mechanism and structure of SKDH.
Some of the kinetic properties of the partially purified E. coli SKDH have 
been reported. It had a pH optimum of 8.5 and the Michaelis constants (Km) determined at 
pH 8.0 were 5 .5 x 1 0 " 5 M and 3 .1 x 1 0 "  ^ M for shikimic acid and NADP+ respectively 
(Yaniv and Gilvarg, 1955). However, the pure enzyme is reported to be more stable at 
higher pH values (Balinsky and Davies, 1961a).
E. coli SKDH is somewhat unusual in being a monomeric dehydrogenase 
(Chuadhuri and Coggins, 1985) since most of the dehydrogenases are larger proteins with 
multimeric structures. The complete polypeptide chain consists of 272 amino acid residues, 
and a deduced molecular weight of 29,414 Da (Anton and Coggins, 1988). One interesting 
feature of the amino acid sequence is the occurrence between residues 121 and 151, the 
amino acid 'fingerprint' characteristic of an ADP binding pajJ-fold (Anton and Coggins, 
1988). The final position in the fingerprint must not be an acidic residue in NADP+ linked 
dehydrogenases (Wierenga et al. 1985, 1986) and in the case of E. coli SKDH this 
position is occupied by a threonine residue. These observations strongly suggest that this 
fold is a part of the nucleotide binding domain of the enzyme.
In order to investigate enzyme-substrate interactions, the specificity of 
E. coli SKDH towards analogues of 3-dehydroshikimic acid (natural substrate), which 
lack the C-4 and C-5 hydroxyl groups and the carbon-carbon double bond has been studied 
(Bugg et a l, 1988). The 5-deoxy analogue was an excellent substrate (kcat = 75 s'^) 
compared to 3-dehydroshikimic acid (kcat = 100 s'^) indicating that the removal of the C-5 
hydroxyl group has little effect on specificity. The removal of the C-4 hydroxyl group in 
the dideoxy analogue (lacking both C-4 and C-5 hydroxyl groups) decreased the kcat value 
to 0.06 s'^ indicating the importance of C-4 hydroxyl group in enzyme-substrate 
interactions. This is consistent with the observation by Balinsky and Davies (1961b) that 
the most effective aromatic inhibitors of the reverse reaction of P. sativum SKDH 
possessed a para hydroxyl group. It has been suggested that this hydroxyl group forms a
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hydrogen bond with a charged group at the enzyme active site (Dennis and Balinsky, 
1972). The dideoxy-dihydro analogue lacking both hydroxyl groups and the double bond 
was also reduced slowly ( k c a t  = 0.09 s"l). Furthermore, the enzyme behaves 
enantioselectively with respect to racemic substrates with a preference for the S~ 
configuration at C-1 and C-4.
1.2.2.4 Isozymes of shikimate dehydrogenase
The existence of isozymic forms of SKDH in a variety of plant species has 
been reported. Early work has shown that SKDH from peas and Phaseolus mungo 
consists of two isozymic forms (Koshiba, 1978). Similarly, SKDH purified from tomato 
fruit resolved into two fractions indicating the presence of two isozymic forms which differ 
in biochemical properties (Lourenco and Neves, 1984). The major fraction had Km values 
of 3.8x10"^ M and 1x10"^ M for shikimic acid and NADP+ respectively. No activity was 
detected when NADP+ was replaced with NAD+. Among a number of inhibitors tested 
only protocatechuic acid functioned as a competitive inhibitor (Ki = 7.7xlO'^M) and several 
divalent metal ions (Hg, Zn and Cu) were also found to be inhibitory. SKDH purified from 
cucumber pulp also contained two isozymic forms and the biochemical properties were 
very similar to the properties observed for the tomato enzyme (Lourenco et al., 1991).
In Ponderosa pine needles SKDH was a monomer and there were three 
allozymes, produced by three different alleles, in the two populations surveyed (Linhart et 
a l, 1981). Any given individual tree had a phenotype of one or at most two of the three 
allozymes.
Plant isozymes have a wide application as genetic markers in agriculture. 
SKDH isozyme systems have been used in cultivar identification and breeding studies of a 
variety of agronomically important plant species such as soybean (Yu and Kiang, 1993), 
banana (Bhat et a l, 1992), lychees (Degani et al, 1995) and strawberry (Williamson gf al, 
1995).
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—1.2.2.5 Quinate-shikimate dehydrogenase
This enzyme is distinct from the biosynthetic SKDH and catalyses the first 
step in the catabolic quinate pathway; the oxidation of quinate and shikimate to 3-DHQ and 
3-DHS respectively. In both prokaryotes and eukaryotes quinate and shikimate are 
converted to protocatechuate by the quinate pathway, which is then metabolised by the p- 
ketoadipate pathway to succinate and acetyl Co-A (Tresguerres et a l, 1970). Quinate 
-shikimate dehydrogenase has been purified and characterised from N, crassa (Barea and 
Giles, 1978), A. nidulans (Hawkins et al, 1993) and from the Gram-positive bacterium 
Rhodococcus rhodochrous (Bruce and Cain, 1990). Its existence has been demonstrated in 
Aspergillus niger (Cain, 1972) and the gene encoding this enzyme in Acinetobacter 
calcoaceticus has recently been sequenced (Elsemore and Omston, 1994).
The coenzyme specificity of catabolic quinate-shikimate dehydrogenases 
show variation among different organisms investigated unlike the biosynthetic SKDH 
which is NADP+ specific. The fungal enzymes and the enzyme from R. rhodochrous are 
NAD+ specific (Cain, 1972; Bentley, 1990; Bruce and Cain, 1990), but the enzyme from 
A. calcoaceticus is reported to be pyrrolo-quinoline quinone (PQQ) dependent (Elsemore 
and Ornston, 1994).
1.3 Objectives of the project
Among the shikimate pathway enzymes, SKDH is one enzyme which has 
not been subjected to extensive study. As a result of the sequencing and overexpression of 
E. coli aro E gene, the amino acid sequence and relatively large amounts of the E. coli 
enzyme had been made available. This has facilitated detailed studies on the structure and 
mechanism of this enzyme. As a part of this study, the main objective of my Ph.D. project 
was to study the active site of E. coli SKDH.
The practical aims were:
(1) To identify residues involved in substrate and coenzyme binding using chemical and 
biophysical methods (group specific chemical modification, electrospray mass spectrometry
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and HPLC) and to further investigate their interactions with the enzyme using substrate 
analogues.
(2) To identify the proposed histidine residue involved in the catalytic mechanism as a 
general acid/base facilitating substrate reduction/oxidation.
(3) To attempt crystallisation of SKDH as a preliminary step towards solving the three 
dimensional structure.
Finally, it is taken into consideration that this enzyme is a potential target for antimicrobial 
and herbicide action. Knowledge of the active site and the identification of enzyme- 
substrate interactions could lead to the design of such potential inhibitors.
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CHAPTER 2
Methodology
    _
2.1 Group specific chemical modification
Chemical modification is of special importance in probing active-site 
structure of enzymes. Of the 20 natural amino acids, only those possessing a polar side 
chain are normally the object of chemical modification. If the reaction of an enzyme with a 
group specific reagent results in the inactivation of the enzyme, it may indicate that an active 
site residue involved in catalysis or binding is modified (Means and Feeney, 1971).
However, there are several limitations to this technique (Eyzaguirre, 1987). 
Most of the commonly used group specific reagents are not absolutely specific for a certain 
amino acid side-chain. The specificity of a reagent can be influenced by experimental 
variables such as pH and buffers. Furthermore, an enzyme may posses many residues of a 
certain amino acid, which can potentially react with a group specific reagent. Therefore, 
absolute specificity for one single amino acid is difficult to achieve. However, active site 
residues often show markedly different pKa values from the free amino acids, and are 
much more reactive. This increases their selectivity towards modifying reagents. When 
more than one residue is modified differential labelling (modification first in the absence 
and then in the presence of substrate) can be used to identify active site residues (Means 
and Feeney, 1971). In the presence of substrate vulnerable residues at or near the active site 
may no longer be accessible to the modifying reagent and therefore will be protected from 
modification.
Interpretation of chemical modification data needs considerable caution. 
Inactivation of an enzyme following chemical modification could result from a 
conformational change in the enzyme. Another possibility is steric hindrance at the active 
site due to the presence of the modifying group, specially if bulky reagents are used. Thus, 
although chemical modification is an effective tool, it is necessary to confirm the function 
assigned to the modified residue by other means. Site-directed mutagenesis is one 
approach, but the protein crystal structure would be the ultimate means by which the active 
site structure is confirmed.
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2.2 Electrospray Mass Spectrometry
Mass spectrometry is an indispensable analytical tool that has been used for 
some time in biochemical research for the analysis of thermally stable small molecules; 
large or thermally labile molecules did not survive the desorption and ionization processes 
intact. This problem had been solved recently with the introduction of electrospray mass 
spectrometry (ESMS) (Fenn e ta l,  1989) and matrix-assisted laser desorption/ionization 
mass spectrometry (MALDI MS) (Karas and Hillenkamp, 1988), thereby allowing mass 
spectrometry to take on new roles in analysis of proteins, peptides and other biopolymers,
ESMS is a sensitive and an efficient technique. It offers picomole-to- 
femtomole sensitivity, and can be used to measure molecular masses up to >200 kDa with 
an accuracy in the order of + 0.01% (Siuzdak, 1994). It can be used to monitor events such 
as phosphorylation, glycosylation, oxidation, disulphide bond formation and protein 
folding (Carr et a l, 1991). Moreover, it can be used to monitor chemical modification of 
proteins (Bordier et a l, 1992; Krell et a l, 1995) since the resolving power of ESMS is 
sufficiently high to distinguish between modified and unmodified protein molecules 
without pre-separation.
The basics of ESMS are shown in Fig. 2.1. The solution of analyte 
molecules is introduced through a silica capillary tube into a strong electrical field where it 
disperses into a fine spray of highly charged droplets. Dry gas, heat or both are applied to 
the highly charged droplets causing the solvent to evaporate. Evaporation causes the droplet 
size to decrease, while surface charge density increases. Multiply charged ions are 
transferred to the gas phase as a result of their expulsion from the droplet. In contrast to ah 
other mass spectrometric ionization methods, the change from the liquid into gas phase is 
thought to occur very gently with at least one solvation shell surrounding the protein (Mann 
and Wilm, 1995). Ions are then directed into the quadrupole analyser through a vacuum 
region where their mass to charge ratios (m/z) are measured. Mass is determined by 
ascertaining the charged states of the peaks and a mass is calculated to each peak in the 
series; alternatively, the series is deconvoluted by a computer algorithm into a single peak 
(Mann e ta l,  1989). |i
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Fig. 2.1 The three principal steps of electrospray mass spectrometry, (a) Formation of small, highly charged droplets by electrostatic dispersion of a solution under the influence of a high electric field, (b) Desorption of protein ions from the droplets into the gas phase, (c) Mass analysis of the ions in a mass spectrometer.
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■The main technical limitation of ESMS is the selectivity in buffers (Mann 
and Wilm, 1995). Ionic buffers disturb the spraying process and compete with the analyte 
molecules for charges, thus such buffers should be avoided in ESMS work. Furthermore, 
involatile substances such as salts and detergents can disturb the desorption process by 
forming a solid core around the droplet from which the ions cannot escape. However, this 
problem can be overcome by desalting the sample prior to analysis.
2.3 HPLC Mass Spectrometry
Electrospray ionization demands a constant delivery of liquid and is 
therefore easily coupled to a liquid-based separation system such as HPLC (Covey et a l, 
1991). This form of mass spectrometry is known as LCMS. The ability to directly analyse 
compounds from aqueous/organic solvents has made ESMS an excellent detector for 
HPLC.
LCMS has a wider application in the protein chemistry field. It is especially 
well suited for the analysis of proteolytic digests of proteins (Meyer et a l, 1993). During 
the HPLC separation of a proteolytic digest, peptides eluting from the HPLC column are 
directly introduced into the mass spectrometer and mass spectra are recorded every few 
seconds. All the ions detected are summed up in a total ion chromatogram and peptides are 
identified by their masses using a software package. However, the use of site-specific 
proteases for proteolysis is of importance in the correct identification of peptides.
LCMS has been successfully employed to locate sites of phosphorylation 
(Meyer e ta l,  1993) and di-sulphide bond formation (Jaquinod e ta l, 1993). Furthermore, 
it can be used to identify sites of group specific chemical modification (Krell et a l, 1995), 
thereby adding a new dimension to active-site studies of enzymes.
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CHAPTER 3
Experimental procedures
:
_______________________
3.1 Materials and reagents
3.1.1 Chemicals and biochemicals
Centricon-10 concentrators were from Amicon Ltd., Stonehouse, 
Gloucestershire, UK.
Ampicillin, benzamidine, phenylmethylsulfonyl fluoride (PMSF), shikimic 
acid, diethylpyrocarbonate (DEPC), hydroxylamine-hydrochloride (NH2OH.HCI), 
phenylglyoxal (PGO), bromophenol blue, Coomasie brilliant blue, N,N,N',N' 
-tetramethylethylene diamine (TEMED) were obtained from Sigma Chemical Co., Poole, 
Dorset, UK.
Bactotryptone and yeast extract were obtained from Difco, Detroit, 
Michigan, USA.
Dithiothreitol (DTT), NAD+, NADP+ and Tris buffer were obtained from 
Boehringer Mannheim, Lewes, Sussex, UK.
Trinitrobenzene sulfonic acid (TNBS), imidazole and 2-mercaptoethanol 
were obtained from BDH Chemicals, Poole, Dorset, UK.
Acrylamide, bisacrylamide, SDS and analytical grade formic acid, were 
obtained from FSA Laboratory Supphes, Loughborough, Leicestershire, UK.
Ultrapure grade guanidium hydrochloride (GdnHCl), urea and isopropyl-p- 
D-thiogalactoside (IPTG) were obtained from BRL,Gibco Ltd., Paisley, Scotland, UK.
HPLC grade water, acetonitrile and trifluoroacetic acid (TEA) were obtained 
from Rathburn Chemicals Ltd., Walkerburn, Scotland, UK. HPLC grade sodium 
phosphate was from BDH Chemicals.
All other chemicals were of analytical grade and were obtained from one of 
the following suppliers: Aldrich Chemical Co. Ltd., Poole, Dorset, UK.; BDH Chemicals; 
FSA Laboratory Supplies; Koch-Light Ltd., Colnbrook, Buckinghamshire, UK.
3 3
_______________________________________________________________________________
3.1.2. Enzymes and proteins
Bovine serum albumin (BSA), deoxyribonuclease I, subtilisin and a 
molecular weight standard marker kit were obtained from Sigma Chemical Co.
TPCK treated bovine trypsin and TLCK treated bovine a-chymotrypsin 
were obtained from Worthington Biochemical Corp., Freehold, New Jersey, USA.
3.1.3. Chromatography media
DEAE-Sephacel, Sephacryl S-200 (superfine grade), 2'5' ADP-Sepharose 
4B and Sephadex G-25 were obtained from Pharmacia, Milton Keynes, Buckinghamshire, 
UK.
3.1.4. Pre-packed media
A pre-packed Mono Q column was obtained from Pharmacia and utilised on 
a Pharmacia FPLC System. Vydac C4 reverse phase columns were purchased from Sigma- 
Aldrich Chromatography, Poole, Dorset, UK. and attached to a Shimadzu HPLC system 
(Shimadzu Corp., Kyoto, Japan). A narrow bore Delta-Pak™ HPI C4 reverse phase 
column was purchased from Waters Chromatography, Watford, Hertfordshire, UK. and 
used on a LCMS system (Shimadzu HPLC apparatus coupled to a VG BioTech Platform 
single quadrupole mass spectrometer from VG BioTech Ltd., Altrincham, Cheshire, 
UK.).
3.2 General laboratory methods
General methods for handling proteins and enzymes were as described in 
Methods in Enzymology; Guide to protein purification, Vol. 182, pp 19-83.(Murray P. 
Deutscher, ed.,1990)
3.2.1 pH measurement
pH measurements were made with a Radiometer Model 26 pH meter 
(Copenhagen, Denmark), calibrated at room temperature.
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3.2.2. Protein estimation
Protein concentrations were estimated by the method of Bradford (1976), 
with BSA as a standard.
3.2.3 Lyophilization
Protein and peptide solutions were collected either into Reacti Vials (Pierce), 
polypropylene tubes (eppendorfs) or 25-100 ml acid washed round bottom flasks and the 
contents frozen by immersing the vessels in a dry-ice/ethanol mixture before lyophilization 
on a FTS Systems (Stone Ridge,New York, USA.) Flexi-Dry freeze dryer.
3.3 SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-polyacrylamide gel electrophoresis was performed by the method of 
Laemmli (1970), with a 5% stacking gel and a 15% running gel. The ratio of acrylamide : 
bisacrylamide in all PAGE experiments was 30 ; 0.8 and polymerisation was induced by 
the addition of 0.03% (v/v) TEMED and 0.05% (w/v) ammonium persulphate. After 
electrophoresis gels were stained for protein by the Coomassie method (Section 3.3.1).
3.3.1 Staining for protein
Gels were stained with Coomassie blue for 30-45 minutes at 40°C for 
visualising of protein. The Coomassie reagent was 0.1% (w/w) Coomassie brilliant blue 
G250 in 50% (v/v) methanol, 10% glacial acetic acid ; destaining was carried out in 10% 
methanol (v/v), 10% glacial acetic acid at 40°C until the background was fully destained 
and bands clearly visible.
3.4 SKDH assay
Although the reaction in the direction of shikimic acid is the one that takes 
place biosynthetically 3-dehydroshikimate and NADPH are less readily available reagents 
than shikimic acid and NADP+. Therefore, the reaction was followed in the reverse 
direction using shikimic acid and NADP+ according to the method of Balinsky and Davies
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(1961a). SKDH activity was assayed by monitoring the reduction of NADP+ at 340 nm 
(e= 6.2x103 M'^cm-l) (Horecker and Komberg, 1948) during the oxidation of shikimate to 
3-dehydroshikimate at 25°C. The standard assay mixture in a total volume of 1ml, 
contained a final concentration of 2 mM NADP+ (coenzyme), 4  mM shikimate (substrate) 
and 100 mM Na2C0 3  pH 10.6. All assays for chemical modification were performed using 
a Gilford/Unicam model 252 UV/Vis spectrophotometer equipped with an external slave 
recorder.
3.5 Cell culture and enzyme purification
3.5.1 Growth of E.coli AB2834/pIA321
Cells of E. coli strain AB2834/pIA321 were grown in L-broth at 37°C on a 
orbital shaker. L-broth containing 10 g/litre Bactotryptone, 5 g/litre yeast extract and 10 
g/litre NaCl was sterilised by autoclaving at 15 psi. D-glucose and ampicillin were added to 
a final concentration of 0.1% (w/v) and 100 rag/litre respectively prior to inoculation. At 
first cells were grown in small feeder cultures ( 3x100 ml of media in 250 ml conical 
flasks) for approximately 20 hr. These feeder cultures were used to inoculate each of 8x500 
ml of fresh media in 2 litre conical flasks. One hour after inoculation isopropyl 1-thio-P-D- 
galactoside (IPTG) was added to a final concentration of 0.5 mM. Incubation was 
continued until growrh ceased (A595 of approximately 5.2) and the cells were then 
harvested by centrifugation using a Beckman 6L centrifuge (4500 rpm for 15 minutes). 
Cells were stored at -20°C. A typical 4 litre culture gave 26 g wet weight of ceUs.
3.5.2 Purification of SKDH
Shikimate dehydrogenase was purified to homogeneity from the E. coli 
AB2834/pIA321 overproducing strain according to the procedure of Chaudhuri et at. 
(1987), except that a final step of chromatography on a Mono Q column using a Pharmacia 
FPLC system was included as in the procedure described for the purification of wild type 
enzyme by Chaudhuri and Coggins (1985).
The specific activity of the purified enzyme was in the range of 950-1050 units/mg.
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3.5.3 Determination of SKDH concentration
The extinction coefficient of purified SKDH was determined by amino acid 
analysis, and was found to be 0.72 (mg/ml) at 280 nm. This value was used in the 
quantification of SKDH in all experiments.
3.6 Characterisation of TNBS mediated inactivation of SKDH
3.6.1 TNBS inactivation reaction
Inactivation was carried out by incubating SKDH (2-3 (iM monomer 
concentration) in the dark with different concentrations of TNBS in 50 mM borate/NaOH 
buffer pH 9.2 at 25°C. Aliquots (10 pi) were withdrawn from the reaction mixture (1 ml) 
at various time intervals and assayed for residual activity as described in section 3.4.
3.6.2 Substrate protection against TNBS inactivation
Protection experiments were carried out by incubating SKDH with 
increasing concentrations of NADP+ (coenzyme) or shikimic acid (substrate) prior to 
addition of TNBS. In a separate experiment SKDH was incubated with a mixture of both 
NADP+ and shikimic acid together in a final concentration of 0.5 mM each prior to addition 
of TNBS. Aliquots were removed at time intervals and were assayed for residual enzyme 
activity. All other conditions were as described in section 3.6.1.
3.6.3 Absorption spectrum of TNBS modified SKDH
SKDH was 90% inactivated by treatment with 35-fold molar excess of 
TNBS in 50 mM borate/NaOH buffer, pH 9.2 at 25°C. The excess reagent was removed 
by dialysis against several changes of buffer. Absorption spectrum of the trinitrophenylated 
enzyme was recorded over the wavelength range 280nm-500nm by using a double beam 
spectrophotometer (Phillips PU 8700) with a reference cell containing the enzyme which 
had been carried through the same treatment except that TNBS was omitted.
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3.6.4 Preparation of TNBS modified SKDH
SKDH (0.3mg) was modified to different extents by treatment with 5-fold 
and 30-fold molar excess of TNBS over protein monomer in 50 mM borate/NaOH buffer 
pH 9.2 at 25®C. After one hour of incubation the sample treated with 5-fold molar excess 
TNBS was 82% active and >75% activity was lost in the sample treated with 30-fold molar 
excess TNBS.
In a parallel experiment SKDH was modified in the presence of substrate 
and coenzyme. SKDH (0.3mg) was first incubated with 2mM NADP+ and 2mM shikimic 
acid and this was followed by the addition of 30-fold molar excess of TNBS. After one 
hour of incubation 86% of the activity remained in the protected sample.
In all three cases the reactions were stopped by gel filtration on Sephadex 
G-25, equilibrated in 10 mM ammonium bicarbonate pH 9.0. Fractions containing enzyme 
activity were pooled and concentrated using centricon-10 (Amicon) cells by centrifuging at 
SOOOxg. In order to remove low molecular weight contaminants all three samples were 
washed thoroughly with HPLC grade water by centrifugation using centricon cells. 
Samples were stored at -20^C and used for electrospray mass spectrometry, reverse phase 
HPLC and on-line LCMS.
3.6.5 Electrospray mass spectrometry (ESMS) and stoichiometry of 
labelling
Stoichiometry of labelling of the samples described in section 3.6.4 was 
determined using ESMS. Samples were analysed on a VG BioTech platform single 
quadrupole mass spectrometer (2-3000 amu range) fitted with a pneumatically assisted 
electrospray source and controlled via the VG Masslynx software. Carrier solvent [l:l(v/v) 
acetonitrile:water with formic acid added to a final concentration of 0 .2% (v/v)] infusion 
was controlled at 10 pl/min using a Harvard syringe pump (Harvard Apparatus, South 
Natic, Mass., USA.). Samples were dissolved in carrier solvent at a concentration of 20 
pmol/pl, centrifuged at 5000xg for 2 min and then 10-20pl samples were injected. The 
MaxEnt deconvolution procedure (Ferridge e ta l ,  1992) was applied for quantitative
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analysis of raw data using 1.0 Da peak width and 1.0 Da channel resolution.
3.6.6 Proteolysis of TNBS modified SKDH
150 |ig from each sample (described in section 3,6.4) were digested with 
chymotrypsin prior to analysis by reverse phase HPLC and LCMS. First the samples were 
denatured by adding one volume of 0.5% ammonium bicarbonate buffer pH 8.0 containing 
8M GdnHCl, and subsequent incubation for 15 min at 30®C. The solution was then diluted 
with 0.5% ammonium bicarbonate buffer pH 8.0, to a final GdnHCl concentration of 2M. 
Chymotrypsin (5% of the mass of substrate) was added at this stage. The digests were 
performed for one hour at 30^C and stopped by freezing the samples in aliquots (2x75 pg) 
in dry ice/ethanol. AU digests were stored at -70°C.
3.6.7 Reverse phase HPLC of peptides
Chymotryptic digests of SKDH modified with 30-fold molar excess TNBS 
in the absence and presence of NADP+ and shikimate were fractionated using a Vydac 
214TP reverse phase C4 column, (4.6 x250 mm) (Sigma-Aldrich) equilibrated in buffer A 
[ 0.1% trifluoroacetic acid in 2:98 (v/v) acetonitrile : water]. 75 pg from each sample were 
injected and the peptides were eluted with a split gradient of buffer B [ 0.1% trifluoroacetic 
acid in 70:30 (v/v) acetonitrile:water] increasing to 70% B in 45 minutes and to 100% B in 
50 minutes, with a flow rate of 1 ml/min. The peptides were monitored 
spectrophotometrically at three different wavelengths simultaneously using a photodiode 
array detector (Shimadzu). Peptides were detected by absorbance at 214 nm and TNBS 
modified peptides were detected by their absorbance at 346 nm and 420 nm.
3.6.8 LCMS
LCMS of the chymotryptic digests of TNBS modified SKDH [82% active 
sample, >75% inactive sample(unprotected) and 86% active sample(protected)] were 
carried out by coupling a Shimadzu HPLC system to VG Biotech platform single 
quadrupole mass spectrometer, using a Delta-Pak HPI C4 column (2.0x150 mm)(Waters)
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and the solvent system mentioned in section 3.6.7. The flow rate applied was 0.3 ml/min, 
and 75 pg from each sample were used for analysis. After injecting the sample the column 
was washed for 8 min to remove GdnHCl using buffer A. The column was developed 
using a split gradient of buffer B, increasing to 70% in 45 minutes and to 100% in 50 
minutes. Peptides eluted were directly introduced into the mass spectrometer with the 
drying gas flow maximised and the source temperature set at lOO^C. The absorption profile 
of the eluted peptides were recorded at 214 nm and mass spectra were recorded at 4 sec 
intervals.
In a control experiment a chymotryptic digest of unmodified SKDH 
(native), digested as described in section 3.6.6, was run under identical conditions as those 
used for TNBS modified samples and spectra were recorded.
3.6.9 Identification of peptides
All the peptides expected to be generated in a chymotryptic digest of SKDH 
and their masses were predicted from the known amino acid sequence data using a 
program in VGMassLynx software. Peptides were identified by the mass/charge values 
generated by this program. Peptides containing modified residues were identified by the 
increase in mass due to the attachment of trinitrophenyl groups.
3.7 Characterisation of PGO mediated inactivation of SKDH
3.7.1 PGO inactivation reaction
SKDH (2-3 jiM monomer concentration) was incubated with different 
concentrations of PGO in 100 mM sodium bicarbonate-carbonate buffer, pH 9.4 at 25®C. 
Aliquots (10 p-1) were removed from the reaction mixture (1 ml) at different time intervals 
and were assayed for residual enzyme activity as described on section 3.4.
.
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3.7.2 Substrate protection against PGO inactivation
SKDH was incubated with NADP+, with shikimate or with a combination 
of both NADP+ and shikimate prior to the addition of PGO. The concentrations used were 
0.2 mM NADP+, 0.4 mM shikimate and 2.5 mM PGO. All other conditions were as 
described in section 3.7.1.
3.7.3 Preparation of PGO modified SKDH
SKDH (0.3 mg) in 100 mM sodium bicarbonate-carbonate buffer, pH 9.4 
at 25°C was modified to different extents by incubating with 0.5 mM and 1.5 mM final 
concentration of PGO (freshly made up 50 mM stock solution in water). Inactivation was 
monitored by removing aliquots from the reaction mixture for enzyme assay. After 30 min 
of incubation, samples were 90% and 60% active respectively. In parallel experiments 
SKDH (0.3 mg) was treated with a final concentration of 3.0 mM PGO in the presence and 
absence of 2.0 mM NADP+. The sample incubated in the absence of NADP+ was 
approximately 35% active and in the presence of NADP+ 93% of the activity was retained 
after 30 min.
In each case reaction was stopped by gel filtration on Sephadex G-25, 
equilibrated with 10 mM ammonium bicarbonate pH 9.0. To remove low molecular weight 
contaminants the samples were washed by diluting with HPLC grade water and 
reconcentrated using Centricon-10 centrifugal concentrators. Samples were stored at -20°C 
and used for electrospray mass spectrometry, reverse phase HPLC and on-line LCMS.
3.7.4 Stoichiometry of incorporation of PGO
The stoichiometry of incorporation of PGO into SKDH was determined by 
ESMS using an aliquot from each sample prepared in section 3.7.3. ESMS was performed 
as described in section 3.6.5.
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3.7.5 Proteolysis of PGO modified SKDH
Tryptic digests of PGO modified SKDH (samples described in section 
3.7.3) were prepared using 160 pg from each sample. First, the samples were denatured in 
0.5% ammonium bicarbonate (pH 8.0) containing 8M urea at 37°C for one hour. Samples 
were diluted to a final urea concentration of 2M with buffer and trypsin (5% of the mass of 
substrate) was added immediately. The digests were performed for 4 hr at 37°C with 
constant stirring. This was followed by a second addition of trypsin (2% of the mass of 
substrate) and digestion was continued for a further 2 hr in order to obtain a complete 
tryptic digest. Digests were frozen in dry ice/ethanol in aliquots (2x80 pg) and were stored 
at -70^C prior to analysis by reverse phase HPLC or LCMS.
3.7.6 Reverse phase HPLC of tryptic digests of PGO modified SKDH in 
the absence of presence of NADP+
Tryptic digests of SKDH modified with 3mM PGO in the absence of 
NADP+ (35% active sample) and in the presence of NADP+ (93% active sample) were 
fractionated using a Vydac 214TP reverse phase column (4.6x250 mm) (Sigma-Aldrich). 
Identical quantities of protein (80 pg) from each sample was injected. Solvent system and 
aU other conditions for elution of peptides were as described in section 3.6.7 except that the 
peptide maps were monitored at 214 nm, the usual wavelength for peptide detection.
3.7.7 LCMS
Tryptic digests of SKDH modified with 3.0 mM PGO in the absence and 
presence of NADP+ (different aliquots of the samples analysed by RP-HPLC in section
3.7.6 ) were analysed by LCMS using a Delta-Pak HPI C4 column (2.0x150 mm) 
(Waters). 80 pg of sample was analysed in each case. Experimental details for LCMS are 
as described in section 3.6.8. In a control experiment a tryptic digest of native SKDH was 
analysed under identical conditions.
1
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3.7.8 Identification of peptides
Masses of all tryptic peptides of SKDH were calculated from the known 
amino acid sequence using VGMassLynx software. Peptides were identified by 
mass/charge values generated by this program and PGO modified peptides were identified 
by the increase in mass.
3.8 Characterisation of DEPC mediated inactivation of SKDH
3.8.1 Determination of DEPC concentration
The concentration of commercially available DEPC may be variable owing 
to hydrolysis. Therefore the concentration of stock DEPC was quantitatively determined by 
reaction with 10 mM imidazole in 50 mM potassium phosphate buffer, pH 7,5. The 
increase in absorbance at 240 nm (s=3200 M"l cm“^ ) (Miles, 1977) due to the formation of 
N-carbethoxy imidazole was read against a reference ceU containing absolute alcohol and 
10 mM imidazole in buffer. The reagent was freshly diluted with ice cold absolute alcohol 
before each experiment.
3.8.2 DEPC inactivation reaction
SKDH (2-3 pM monomer concentration) was incubated with DEPC in 50 
mM sodium phosphate buffer, pH 7.0 at 25°C. The final concentration of ethanol in the 
reaction mixture (1 ml) was kept below 5% (v/v) so as not to affect enzyme activity. 
Aliquots (100 pi) were removed at time intervals from the reaction mixture and quenched 
with 200 pi 20 mM imidazole and diluted with 50 mM sodium phosphate buffer, pH 7.0 
and then the residual enzyme activity was determined as described in section 3.4.
3.8.3 Substrate protection against DEPC inactivation
SKDH was incubated with NADP+ or with shikimate or with a combination 
of both NADP+ and shikimate prior to addition of DEPC. All other conditions were as 
described in section 3.8.2,
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3.8.4 Carbéthoxylation and decarbethoxylation
A double beam spectrophotometer (Philllips/PU8700) equipped with a 
thermostatically controlled cuvette holder and a data storage facility was used to determine 
the time dependent N-carbethoxylation of histidine residues by increase in the absorbance at 
240 nm in 1 ml reaction volume in 50 mM sodium phosphate buffer, pH 7.0. Reference 
spectra of 1.0 mg of enzyme in buffer and ethanol were recorded over the wavelength 
range 220-350 nm and then subtracted from sample spectra recorded using 1.0 mg of 
enzyme in buffer and DEPC (1.0 mM) to generate difference spectra. The number of 
modified histidine residues as a function of time were calculated using the molar extinction 
coefficient for N-carbethoxyhistidine (8240= 3200 M“l cm‘l)(Miles, 1977).
Decarbethoxylation was carried out by adding an equal volume of neutral 
hydroxylamine to both reference and sample cuvettes when the enzyme was approximately 
80% inactivated due to carbéthoxylation. Spectra were recorded after one, two and three 
hours of addition of neutral hydroxylamine.
Carbéthoxylation and decarbethoxylation were correlated to activity by 
assaying aliquots withdrawn from the reaction mixtures at various times during the 
experiment.
3.8.5 pH dependence of DEPC inactivation
The pH dependence of DEPC inactivation was determined in 50 mM 
sodium phosphate buffer over the pH range 5.5 - 7.1 at 25®C. All other conditions were as 
described in section 3.8.2.
3.8.6 Preparation of DEPC modified SKDH
SKDH (0.2 mg) was incubated with 30-fold molar excess of DEPC in 50 
mM sodium phosphate buffer pH 7.0 at 25°C in the absence and presence of NADP+ and 
shikimate (final concentration 5.0 mM each). After 30 minutes of incubation >70% activity 
was lost from the sample incubated in the absence of NADP+ and shikimate (unprotected 
sample) whereas 65% of the activity retained in the protected sample.
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Reactions were stopped by gel filtration on Sephadex G-25, equilibrated 
with 10 mM sodium phosphate buffer, pH 7.0. Samples were washed thoroughly with 
HPLC grade water and reconcentrated using Centricon-10 centrifugal concentration cells. 
Samples were stored at -20®C.
3.8.7 Determination of stoichiometry of incorporation of DEPC
The stoichiometry of incorporation of DEPC into SKDH was determined by 
ESMS using an aliquot from each of the samples prepared in section 3.8.6. ESMS was 
performed as described in section 3.6.5.
3.8.8 Proteolysis of DEPC modified SKDH
100 pg each of DEPC modified SKDH in the absence and presence of 
NADP+ and shikimate (samples prepared in section 3.8.6) were digested using subtilisin. 
The samples were denatured in 50 mM sodium phosphate buffer pH 7.0 containing 8M 
GdnHCl for 15 minutes at 30®C. The solution was then diluted to a final GdnHCl 
concentration of 2M with buffer. Subtilisin (5% of the mass of substrate) was added at this 
stage and the digests were performed for 2 hours at 30°C with continuowstirring. This was 
followed by immediate freezing of digests in dry ice/ ethanol and storage at -70*^ C prior to 
fractionation by RP-HPLC.
3.8.9 Reverse phase HPLC of peptides
The digests were fractionated using a Vydac 214TP reverse phase C4 
column (4.6x250 mm) (Sigma) equilibrated in buffer A (10 mM sodium phosphate, pH 
6.4). Identical quantities (100 pg) of protein were injected from each sample. The column 
was developed with a split gradient of buffer B (10 mM sodium phosphate, pH 6.4 in 
70:30 acetonotrile:water) increasing to a 70% B in 45 minutes and then to 100% B in 50 
minutes. Peptide maps were monitored at 214 nm which is the common wavelength for 
peptide detection and at 240 nm for the detection of DEPC modified peptides. Peptides 
protected from DEPC modification by substrate and coenzyme were collected manually and
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freeze dried using acid washed glassware [Glass Reacti Vials (Pierce) soaked overnight in 
6N HNO3 and rinsed exhaustively with distilled water] and stored at -20^C.
m.
3 .8.10 Sequence analysis of isolated peptides
Isolated peptides were sequenced on an Applied Biosystems Model 470A 
Gas-phase sequencer with on-line detection of amino-acid thiohydantoins by a model 120A 
analyser. The instrument was operated by Dr. B. Dunbar at The Protein Sequencing 
Facility, University of Aberdeen.
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CHAPTER 4
The essential lysine residue at the active-site of 
Escherichia coli shikimate dehydrogenase
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4.1 Introduction
The epsilon amino group of lysine in itk unprotonated form is a highly 
reactive nucleophile and permits selective modification with chemical reagents. The average 
pKa of this group is around 10 but this can be significantly altered by microenvironmental 
effects on the surface of the protein molecule as in the case of acetoacetate decarboxylase, 
where a value as low as 5.9 has been reported for a reactive lysine (Schmidt and 
Westheimer, 1971).
At the active sites of enzymes lysines may be functionally significant 
residues involved in catalysis or binding. Many cases have been reported where the positive 
charge of the epsilon amino group has mediated the binding of negatively charged 
substrates via charge interactions; in glucose-6 -phosphate dehydrogenase from 
Leuconostoc mesenteroides Lys-21 interacts with the phosphate group of glucose-6- 
phosphate (Milhausen and Levy, 1975; Lee and Levy, 1992) while in human glutathione 
transferase Pl-1, Lys-45 interacts with the glycine carboxylate of glutathione (Widersten et 
a/., 1992). Furthermore in many pyridine nucleotide dependent enzymes lysine side chains 
have been implicated in coenzyme binding, such as Lys-21 and Lys-262 in human aldose 
reductase (Wilson et a l, 1992) and Lys-183 of lobster G3PDH (Buehner et a l, 1973). In 
class I aldolases and in type I dehydroquinases lysines play a catalytic role in reacting with 
carbonyl groups of substrates to form Schiff base intermediates (Horecker et a l, 1970; 
Chaudhuri et a l, 1991). In PLP dependent enzymes, the coenzyme binds in an imine 
linkage to the e-amino group of an active-site lysine residue, thus converting the enzyme 
into an active aldimine form to facilitate catalysis (Braunstein, 1970).
In the studies leading to the characterisation of the active site of E.coli 
SKDH, involvement of a lysine residue in the mechanism of action was postulated. In 
preliminary experiments inactivation of SKDH with methyl benzimidate (MB) and with 
2,4,6-trinitrobenzenesulfonic acid (TNBS), both lysine specific reagents, suggested the 
presence of an important lysine residue. The present chapter describes experiments leading 
to the identification of an essential lysine at the active site of this enzyme.
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4.2 Chemical modification with TNBS
4.2.1 Background
TNBS was originally introduced by Okuyama and Satake (1960) as a 
reagent to selectively react with primary amino groups of amino acids and proteins. In the 
absence of available primary amines it may react with sulfhydryl groups (Kotaki et al., 
1964) but no reaction has been detected with the hydroxyl groups of serine, threonine nor 
tyrosine nor with guanido or imidazole groups (Okuyama and Satake, 1960; Satake et a l, 
1960). The reaction yields a trinitrophenyl (TNP)-amino derivative with the displacement of 
a sulphite ion from TNB S (Fig 4.1).
The ultraviolet absorption spectrum of this derivative shows a characteristic 
absorption maximum at 345-348 nm and a broad shoulder at 420 nm (Okuyama and 
Satake, 1960; Kotaki et a l, 1964), Sulfite ions formed during the reaction associate with 
TNP-amino groups to form complexes, altering the absorption spectrum by increasing it at 
420 nm and decreasing at 346 nm. However in the presence of excess sulfite, absorbance 
of the sulfite complex measured at 420 nm (e = 2.0 x 10  ^M"1 cm~l) is the most sensitive 
index for quantification of the reaction (Lundblad and Noyes, 1984).
The reaction of TNBS with amines is strongly pH dependent, since only 
the unprotonated form reacts (Goldfarb, 1966; Freedman and Radda, 1968). Reactivity to 
TNBS is a sensitive measure of the basicity of the amino group which may be influenced 
by adjacent charged groups.
#
4.2.2 Kinetics of TNBS inactivation of SKDH
In pseudo first-order kinetics [I] »  [E] (I and E represents inhibitor and 
enzyme respectively) and the rate of the reaction (v) is given by,
V = kobs [E] ............ equation (1)
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which can be rewritten as,
-d[E a] /  dt =  kobs[Ea]   equation (2)
where [Eg] is the enzyme concentration at time t and kobs is the pseudo first-order rate 
constant. Integration of equation (2) with respect to [Ea] between times 0 and t gives a 
relationship between the natural logarithm of the fractional activity of the enzyme and the 
time;
ln[Ealt/ [Ealo -  -kobs t ............ equation (3)
and conversion to a common logarithmic form gives the following equation.
log [Ealt/[Ea]o = -kobs/2.303 t ............ equation (4)
Therefore logarithm of the fraction of activity remaining against time gives a straight line in 
a pseudo first-order plot ( Byzaguirre, J., 1987).
Incubation of E. coli SKDH with TNBS at 25®C in 50 mM borate/NaOH 
buffer pH 9.2, resulted in a rapid loss of enzyme activity. In control experiments, in the 
absence of TNBS no loss of activity was detected. The fraction of activity remaining 
(At/Ao, where At is the activity at a given time and Ao is the initial activity i.e. at 0 time) 
was calculated as the percentage of activity remaining at a given time (t). The plot of 
logarithm of percent remaining activity against time at various concentrations of TNBS 
showed pseudo first-order kinetics (Fig 4.2 A). The rate of inactivation was dependent on 
TNBS concentration.
The pseudo first-order rate constants (kobs) for inactivation at various 
TNBS concentrations were calculated using the following expression:
kobs = lit 2/ t i /2 = 0.693/ ti/2 .........  equation (5)
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where ti /2 (half life) is the time after which the activity has decreased to half of its original 
activity, i.e. time when At-Ao/2. The half life of inactivation at various concentrations of 
TNBS were measured directly from the pseudo first-order plot. The results are summarized 
in Table 4.1.
Table 4.1 
Half life (ti/%) and pseudo first-order rate constant (kobs) for the 
inactivation of SKDH at different concentrations of TNBS
[TNBS] mM t(i/2) min kobs/m in
0 .0 3 0 50.1 0.014
0 .0 5 0 31.2 0.022
0 .1 0 0 16.5 0.042
0 .1 5 0 11.5 0.060
0 .175 9.7 0.071
The relationship between the rate constant and the inhibitor concentration in 
pseudo first-order kinetics may be expressed as:
kobs = k [I]^ .......... equation(6)
where n is the order of reaction with respect to [I], kobs is the pseudo first-order rate 
constant and k is the second-order rate constant (Levy et a l, 1963).
The plot of pseudo first-order rate constants (kobs) &s a function of TNBS 
concentration (Fig. 4.2 B) yielded a straight line passing through the origin which indicated
5 0
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Fig. 4.2 Kinetics of inactivation of SKDH with TNBS 
Fig. 4.2 A. Pseudo first-order plots for inactivation
SKDH (2-3 |iM) was incubated with increasing concentrations of TNBS in 50 mM 
borate/NaOH buffer, pH 9.2 at 25°C. Aliquots were removed at time intervals and 
assayed for residual activity as described in section 3.4.The concentrations of TNBS used 
were 0.03 mM(B), 0.05 mM(4 ), 0.10 mM(a), 0.15 mM(^) and 0.175 mM(«).
Fig. 4.2 B. Determination of the second-order rate constant of inactivation
Pseudo first-order rate constants (kobs) calculated in part A were replotted against TNBS 
concentration. The second-order rate constant (k) calculated from the slope of this plot 
was 405 M'lmin L
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Fig. 4.2 C. Determination of the order of the reaction
The order of reaction with respect to TNBS calculated from the slope of this plot was L07, 
which indicates that TNBS mediated inactivation of SKDH results from the modification of 
a single lysine residue.
i
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that the inactivation is a bimolecular process and a dissociable enzyme-TNBS complex was 
not formed prior to inactivation (Kitz and Wilson, 1962; Church et al, 1985). The second- 
order rate constant (k) calculated from the slope was 405 M‘l min f
■ I
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The kinetic order of the reaction can be estimated from the logarithmic form of equation (6): 
log kobs = n log [I] + log k .........  equation (7)
where n is the kinetic order of the reaction or minimal number of reagent molecules needed 
to inactivate a single molecule of active enzyme unit (Levy et a l , 1963). A plot of log kobs 
against log [TNBS] yielded a straight line with a slope near unity (1.07) (Fig. 4.2 C).This 
indicates that the TNBS mediated inactivation of SKDH results from the modification of a 
single lysine residue.
4.2.3 Substrate protection against TNBS inactivation
Retention of enzyme activity following modification in the presence of 
substrate may indicate that inactivation is active site directed (Means and Feeney, 1971). In 
the presence of substrate vulnerable residues at or near the active site may no longer be 
accessible to the modifying reagent and provides a criterion for the identification of active site 
residues.
SKDH activity could be protected against TNBS inactivation by prior 
addition of NADP+ (coenzyme) (Fig.4.3 A) or shikimate (substrate) (Fig.4.3 C). In both 
cases the % protection offered increased with concentration as illustrated in Tables 4.2 and
4.3 respectively. % protection was calculated by,
[kobs(unprotected) - kobs(protected)/ kobs(unprotected)] x 100
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Protection occurred at low concentrations of NADP+ and higher concentrations of 
shikimate. The Ks values for NADP+ and shikimate at pH 9.2 determined from these data 
are 70 pM (Fig.4.3 B) and 240 )j.M (Fig.4.3 D) respectively. These data indicate that 
NADP+ binds more tightly to the free enzyme than shikimate. However maximum 
protection occurred in the presence of both NADP+ and shikimate (Fig. 4.3 E) suggesting 
that the ternary complex is more stable than the binary complexes. It is interesting that 
shikimate alone does afford some protection, which is enhanced in the presence of 
NADP+. This may indicate that the proper binding of shikimate to the enzyme occurs in the 
presence of NADP+.
Table 4.2
Effect of NADP+ concentration on SKDH inactivation by TNBS
[NADP+] t i /2 (min) kobs/nnn % Protection
0.0 mM 5.2 0.133 0
0.1 mM 13.2 0.052 61
0.2 mM 19.0 0.036 73
0.3 mM 30.0 0.023 83
0.4 mM 36.0 0.019 86
______________
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Fig. 4.3 A. Protection with NADP+ against TNBS inactivation
SKDH (2-3 |iM) was incubated with 0.25 mM TNBS in the presence of increasing 
concentrations of NADP+. Aliquots were withdrawn at time intervals and were assayed 
for enzyme activity. NADP+ concentrations used were OmM (a), G.lmM(4 ), 0.2mM(a), 
0.3mM(^) and 0.4mM(«).
Fig. 4.3 B. Determination of Ks for NADP+
The half life of values calculated from part (A) were plotted against NADP+ 
concentrations. The Ks value for NADP+ determined from the intercept of this plot is 70 
|iM.
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Fig. 4.3 C. Protection with shikimate against TNBS inactivation
SKDH (2-3 nM) was incubated with 0.25 mM TNBS in the presence of increasing 
concentrations of shikimate. Aliquots were withdrawn at time intervals and were assayed 
for enzyme activity. The concentrations of shikimate used were OmM(Q), 0.2mM(^), 
0.4mM(B), 0.6mM(^) and 0.8mM(«).
Fig. 4.3 D. Determination of Ks for shikimate
The half-life values calculated from part (A) were plotted against shikimate 
concentrations. The value of Ks for shikimate determined from the intercept of this plot is 
240 i^M.
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Fig. 4.3 E. Protection against TNBS inactivation in the presence of a 
mixture of NADP+ and shikimate
SKDH (2-3 pM) was incubated with 0.175mM TNBS alone(Q), in the presence of 0.5mM 
shikimate (♦), 0.5 mM NADP+ (b) and a mixture of 0.5mM NADP+ and shikimate (^). 
Pseudo first-order rate plots shown in this figure indicates that maximum protection against 
TNBS inactivation is obtained in the presence of both NADP+ and shikimate.
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Table 4.3
Effect of shikimate concentration on SKDH inactivation by TNBS
[Shikimate] t i / 2 (min) kobs/min % Protection
0.0 mM 4.6 0.151 0
0.2 mM 7.5 0.092 39
0.4 mM 12.2 0.057 62
0.6 mM 15.8 0.044 71
0.8 mM 19.0 0.036 76
4.2.4 Characterization of TNBS-modified SKDH
TNBS preferentially reacts with primary amino groups of proteins but it 
may also react with sulfhydryl groups forming S-TNP derivatives (Kotaki et a l, 1964). 
There are three cysteine residues in the amino acid sequence of SKDH and the possibility of 
a cysteine residue reacting with TNBS could not be ruled out without investigation.
The UV absorption spectrum of TNBS-modified SKDH (90% inactivated) 
was identical with that of a TNP-amino derivative (Fig.4.4), with a characteristic 
absorption maximum at 345-348 nm and a pronounced shoulder at 420 nm (Okuyama and 
Satake, 1960; Kotaki et a l, 1964). This excluded the possibility of a cysteine residue 
reacting since S-TNP cysteine has no maximum in this region and shows intense end 
absorption at low wavelengths (Kotaki et a l, 1964; Hollenberg et a l, 1971). Furthermore, 
the S-TNP linkage is labile in alkaline solution (Kotaki et a l , 1964) and would not remain 
intact at pH 9.2, the pH at which the spectrum was recorded.
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Fig. 4.4 Absorption spectrum of TNBS modified SKDH
Absorption spectrum of TNBS modified SKDH recorded against a reference cell containing 
the unmodified enzyme in buffer, revealed an absorption maximum at 346-348 nm and a 
shoulder at 420 nm characteristic of a TNP-amino derivative.
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4.2.5 Stoichiometry of incorporation of TNBS into SKDH
SKDH was inactivated to different extents by treatment with TNBS in order 
to measure the stoichiometry of incorporation using ESMS. An aliquot from each sample 
prepared in section 3.6.4 was subjected to ESMS in the positive ion mode as described in 
section 3.6.5, The MaxEnt deconvolution procedure was applied for quantitative analysis 
of raw data using 1.0 Da peak width and 1.0 Da channel resolution (Ferridge et al, 1992).
The electrospray profile of the partially modified sample (82% active after 
treatment with 5-fold molar excess TNBS) revealed only one adduct with a molecular mass 
of 29,625 Da (Fig. 4.5 A). The molecular mass of native SKDH deduced from the amino 
acid sequence is 29,414 Da. Attachment of a trinitrophenyl group as a result of reaction 
between TNBS and lysine would increase the mass by 211 Da. Therefore 29,625 Da 
(29,414+211) relates to an enzyme species containing a single modified lysine.
SKDH treated with 30-fold molar excess TNBS in the absence of substrate 
and coenzyme was extensively modified and >75% activity was lost. Electrospray spectrum 
of this sample showed three adducts with masses of 29,625 Da (29,414+211) ; 29,836 Da 
(29,414+422) and 30,047 Da (29,414+633) (Fig. 4.5 B). These adducts correspond to 
enzyme species with one, two and three modified lysines respectively.
In the presence of substrate and coenzyme incorporation of TNBS was 
greatly reduced compared with the previous sample although the same amount of reagent 
(30-fold molar excess) was used. The protected sample was 86% active and the 
electrospray spectrum revealed only a single adduct with a mass of 29,625 Da (29414+211) 
relating to enzyme species with one modified lysine residue (Fig. 4.5 C). This clearly 
indicates that two lysine residues recognised by TNBS are no longer available for 
modification in the presence of substrate and coenzyme. Thus, by the criteria of protection 
by substrate and stoichiometry of modification it appears that two lysine residues are 
functionally important in the catalytic mechanism of SKDH.
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Fig.4.5 Determination of the stoichiometry of incorporation of TNBS into SKDH by
ESMS
A, Partially modified (82% active) SKDH with TNBS
ESMS profile of the partially modified sample revealed two species of different 
molecular masses. The species with a molecular mass of 29,414 Da relates to unmodified 
SKDH (E) and the species with +211 mass difference (Mr=29,625 Da) relates to SKDH 
with one modified lysine.
B Extensively modified (>75% inactive) SKDH with TNBS
ESMS profile of the extensively modified SKDH revealed three modified species having 
mass differences of +211 (Mr~29,625 Da), +422 (Mr=29,836 Da) and +633 (Mr=30,047 
Da) indicative of one, two and three modified lysines respectively.
C. SKDH modified with TNBS in the presence of shikimate and NADP+(86% 
active)
ESMS profile of the protected sample revealed only one adduct with a mass difference of 
+211 (Mr=29,625 Da) relating to enzyme species with one modified lysine residue. 
Accordingly, two lysines are protected from TNBS modification in the presence of 
shikimate and NADP+.
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4.3 Identification of substrate protected lysines by differential peptide 
mapping
Stoichiometric analysis of TNBS modified SKDH indicated that up to three 
lysines can be labelled in an extensively modified sample, and in the presence of NADP+ 
and shikimate two out of the three are protected from modification. In order to identify the 
lysines protected by substrate differential peptide mapping approach was employed. This 
technique allows identification of regions of the protein which are modified by a reagent but 
are protected in the presence of substrate. TNBS labelled peptides can be detected by their 
absorbance at 346 nm and 420 nm and therefore it was not necessary to use radioactive 
TNBS to identify the modified peptides.
4.4 Differential peptide mapping of TNBS modified SKDH
Differential peptide mapping was done using chymotryptic digests of SKDH 
modified with a 30-fold molar excess of TNBS in the absence and presence of NADP+ and 
shikimate. The digests were fractionated by reverse phase HPLC using a Vydac 214TP C4 
column as described in section 3.6.7. Peptides were eluted with a split acetonitrile gradient 
and monitored at three different wave lengths; 214 nm for detection of peptides, 346 nm 
and 420 nm for the detection of peptides containing TNP-lysine residues.
The HPLC profile at 346 nm and 420 nm of the unprotected sample, 
revealed many peptides containing modified residues, located in the hydrophobic region of 
the peptide map (Fig. 4.6.A). However, as revealed by ESMS data the unprotected sample 
contained only three modified residues. Therefore it appears that the modified residues are 
contained in large hydrophobic peptides which are further cleaved into partial peptides upon 
prolonged incubation. The HPLC profile of the protected sample showed significant 
protection by the disappearance of a number of peaks (Fig. 4.6.B) at 346 nm and 420 nm 
although ESMS revealed only two residues were protected. Therefore identification of any 
two particular peptides relating to the two protected residues proved difficult. In order to 
overcome this problem and to identify the substrate protected lysines a different approach 
where the HPLC was coupled to the mass spectrometer (LCMS) was taken.
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Fig. 4.6 Differential peptide mapping by RP-HPLC
HPLC profiles of chymotryptic digests of TNBS modified SKDH in the absence (A) 
and in the presence (B) of shikimate and NADF+
Experimental details are given in section 3.6.7. Identical quantities of protein were 
injected (100 |ig) and peptide maps were monitored at 214 nm for the detection of 
peptides, 346 nm and 420 nm for the detection of peptides containing modified lysine 
residues. mAbs represents milli absorbance units.
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4.5 Localization of TNBS labelled lysines by LCMS
In an attempt to identify TNBS labelled lysines in the absence and presence 
of substrate the approach of LCMS was employed. In this technique individual masses of 
the peptides eluting from the HPLC column are measured by the mass spectrometer and 
peptides are identified by their masses. The presence of a TNP group as a result of 
modification would increase the theoretical mass of a peptide by +211 Da. Chymotrypsin 
specifically hydrolyses the carboxy terminal amide bonds of phenylalanine, tyrosine and 
tryptophan. Accordingly, in a chymotryptic digest the eight lysines in the SKDH sequence 
would be localized on seven peptides, one containing two lysines. Therefore by scanning 
each lysine containing peptide for a mass difference of +211 Da, peptides containing 
modified lysines could be identified. The presence of a signal for a mass difference of +211 
Da in the unprotected sample and its absence in the substrate protected sample would allow 
the identification of the protected lysine residues.
4.6 LCMS of TNBS modified SKDH
LCMS of the chymotryptic digests of TNBS modified SKDH were 
performed as described in section 3.6.8 using a Delta-Pak HPIC4 column, and the column 
was developed using a split acetonitrile gradient.
In the control experiment, a chymotryptic digest of unmodified SKDH 
(native) was analysed. Out of the seven lysine containing peptides six were identified by 
scanning their masses.
The partially modified sample (82% active after treatment with 5-fold molai' 
excess TNBS) contained one modified lysine as revealed by ESMS. The chymotryptic 
digest of this sample was analysed on LCMS. EachJysine containing peptide was scanned 
for a mass difference of +211 Da. As a result of this scan one peptide with an added mass 
of 211 Da was identified. This peptide is referred to as peptide Cl (Table 4.4). The HPLC 
trace and the mass scan of the doubly protonated ion of peptide C l+211 are shown in Fig.
4.7.1 (A) and (B) respectively.
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Table 4.4
Peptide Sequence M+2H/2 Da
Cl 52sAGGK GANVT VPFKE EAF^^ 1011.01
(M= mass of peptide + 211 Da, H= LOO Da)
Considering the specificity of chymotrypsin, peptide C l consists of two 
partial peptides referred to as peptide Cl (A) - SAGGK GANVT VPF and peptide C1(B) - 
KEEAF. Modification of Lys-65 has resulted in the loss of a chymotrypsin sensitive site 
between ^"^Phe-Lys^^ due to the bulky nature of the trinitrophenyl group. Thus, the 
appearance of peptide Cl can be explained. Also, the presence of a peak corresponding to 
the mass of C l (A) [Fig.4.7.1(C)j and the absence of a peak corresponding to the mass of 
C1(A)+211 [Fig.4.7.1(D)] provides further evidence that the lysine residue modified in 
peptide Cl is Lys-65.
The sample treated with 30-fold molar excess of TNBS in the absence of 
substrate and coenzyme was >75% inactive, and contained three modified lysines as 
revealed by ESMS. Mass scans following LCMS of the chymotryptic digest of this sample 
resulted in the identification of three peptides with added masses of 211 Da. These peptides 
are referred to as Cl (already identified in the 82% active sample), C2 and C3 (Table 4.5). 
The HPLC trace and the mass scans of the doubly protonated ions of Cl+211, C2+211 and 
C3+211 of this sample are shown in Fig. 4.7.2(A)-(D) respectively.
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Fig. 4.7 LCMS
4.7.1 LCMS of the partially modified SKDH (82% active) with TNBS
HPLC trace (at 214 nm) of the chymotryptic digest of partially modified SKDH (A) , 
mass scans for the doubly protonated ions of peptides C l+211 (B) , C l (A) (C) and 
Cl (A)+211 (D) illustrating that the lysine residue modified in peptide Cl is Lys-65 and 
not Lys-56.
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4.7,2 LCMS of the extensively modified SKDH (>75% inactive) with TNBS
HPLC trace (at 214 nm) of the chymotryptic digest of extensively modified SKDH (A), 
mass scans for the doubly protonated ions of peptides Cl+211 (B), C2+211 (C) and 
C3+211 (D). These data indicate that the three modified lysine residues are Lys-65 , Lys- 
15 and Lys-217/219 contained in peptides C l, C2 and C3 respectively.
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4.7.3 LCMS of SKDH modified with TNBS in the presence of substrate and 
coenzyme (86% active)
HPLC trace (at 214 nm) of the chymotryptic digest of TNBS modified SKDH in the 
presence of substrate and coenzyme (A), mass scans for the doubly protonated ions of 
peptides Cl+211 (B), C2+211 (C) and C3+211 (D) indicating that the two protected 
lysines by substrate and coenzyme are Lys-65 and Lys-15 contained in peptides Cl and 
C2 respectively.
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Table 4.5
Peptide Sequence M+2H/2 Da
Cl 52sAGGK GANVT VPFKE EAF69 1011,01
C2 Sg n p ia  h s k s p  f 18 683.64
C3 216q k GKT PF222 508.97
(M=mass of peptide+211, H=1.00 Da)
From these results it can be concluded that the three lysines modified in the 
>75% inactive sample are Lys-65, Lys-15 and Lys-217/219.
The sample modified in the presence of NADP+ and shüdmate was 86% 
active and contained only one modified residue as shown by ESMS. This residue was 
identified as Lys-217/219 by mass scans following LCMS of the chymotryptic digest of 
this sample. In comparison with the unprotected sample a weak signal was obtained for the 
mass of C2+211 suggesting that Lys-15 was substantially protected by NADP+ and 
shikimate. No signal was obtained for the mass of Cl+211 indicating complete protection. 
The HPLC trace and the mass scans of the doubly protonated ions of peptides Cl+211, 
C2+211 and C3+211 in the protected sample are shown in Fig. 4.7.3 (A)-(D). From these 
results it can be concluded that Lys-65 is completely protected whereas, Lys-15 is partially 
protected by NADP+ and shikimate.
4.7 The essential lysine residue at the active site of E, coli SKDH
ESMS and LCMS data together indicate that Lys-65 is completely protected 
and Lys-15 is partially protected by substrate and coenzyme from TNBS modification. 
Therefore it appears that both these residues are in the active site of SKDH. However, 
analysis of kinetic data (section 4.2.2) suggests that only one essential lysine is responsible 
for the TNBS mediated inactivation of SKDH. This may be explained by comparison of
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SKDH sequences from different organisms (Fig. 4.8). Of the two protected residues Lys- 
65 is a conserved residue. In fact out of the eight lysines in the E. coli sequence Lys-65 is 
the only conserved lysine among all known SKDH sequences. Lys-15 is conserved in three 
species, namely P. aeruginosa, N. tabacum and P, sativum but is replaced by Arg in A. 
nidulans and S. cerevisiae sequences and by Gin in B, aphidicola and F. carinii 
sequences. It is possible that Lys-15 is present in the vicinity of the actve-site, and the 
binding of substrate and coenzyme at the active-site have blocked a bulky molecule like 
TNBS from reacting with Lys-15. Thus, considering the data from the kinetic analysis and 
the complete protection of Lys-65 by substrate and coenzyme together with its conservation 
among all known sequences it is reasonable to conclude that Lys-65 is essential to the 
catalytic mechanism of SKDH.
4.8 The role of Lys-65
The observation that shikimate affords protection against TNBS 
inactivation and that this protection is enhanced in the presence of NADP+, suggested a 
possible role for Lys-65 in shikimate binding. Lysine residues can mediate the binding of 
negatively charged substrates. Thus, an ionic interaction between the carboxylate group of 
shikimate and the e-amino group of Lys-65 was a strong possibility. However, the C-4 
hydroxyl group of shikimate has been shown to be important in substrate binding, and a 
hydrogen bonding interaction between this hydroxyl group and the enzyme active site has 
been suggested (Bugg et a l, 1988). Therefore, the possibility of Lys-65 interacting with 
the C-4 hydroxyl group could not be ruled out without investigation.
In order to investigate the above mentioned possibilities protection 
experiments against TNBS inactivation were repeated using methyl shikimate, an analogue 
of shikimate. In methyl shikimate the carboxyl group is blocked by converting to a methyl 
ester. Therefore, if Lys-65 is interacting with the carboxyl group of shikimate, methyl 
shikimate would not be able to afford any protection against TNBS modification, whereas 
an interaction between Lys-65 and the C-4 hydroxyl group of shikimate would not be 
affected by methyl shikimate. Results of this experiment are shown in Fig.4.9.
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Fig. 4.9 Protection with methyl shikimate and shikimate against TNBS 
inactivation
SKDH was incubated with 0,20 mM TNBS alone (la), or in the presence of 0.8 mM methyl 
shikimate (♦), or 0.8 mM shikimate («), Aliquots were withdrawn at time intervals and 
were assayed for remaining activity.
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The results indicate that methyl shikimate is not able to afford any 
protection against TNBS modification, while shikimate in same concentration affords 
significant protection. Thus it can be concluded that Lys-65 plays a role in substrate binding 
at the enzyme active site, via an ionic interaction between the e-amino group and the 
carboxyl group of shikimate.
4.9 Discussion
In order to investigate the involvement of a lysine residue at the active site of 
E. coli SKDH and to propose a possible role in the mechanism of action, chemical 
modification with lysine specific reagents were attempted. In preliminary experiments 
SKDH was treated with methyl benzimidate, an imidoester. Imidoesters react in alkaline 
solution with amino groups of proteins to form imidoamides (Hunter and Ludwig, 1962; 
1972). Prolonged incubation of SKDH with methyl benzimidate resulted in the inactivation 
of the enzyme. Inactivation was a slow process with a rate constant of 12 M'^ hr'l. 
Chemical modification with TNBS also resulted in the loss of activity, in a rapid 
inactivation process. Substrate and coenzyme afforded protection against both methyl 
benzimidate and TNBS inactivation. These data suggested the presence of a lysine residue 
at the enzyme active site. To investigate this and to identify the active site lysine, further 
experiments were carried out using TNBS to chemically modify the protein. TNBS was 
preferred to methyl benzimidate since the reaction with methyl benzimidate was very slow 
and required high reagent concentrations.
Incubation of SKDH with TNBS resulted in a rapid loss of enzyme activity 
following pseudo first-order kinetics. The second-order rate constant of inactivation was 
405 M“1 min'l indicative of a highly reactive group at pH 9.2. The kinetic order of the 
reaction with respect to TNBS was 1.07 indicating that inactivation resulted due to the 
modification of one residue per active site. Sulfhydryl groups may react with TNBS but are 
less reactive than amino groups (Kotaki et a l, 1964). However this possibility could not be 
dismissed without further study. The UV absorption spectrum of TNBS modified SKDH 
provided the evidence to rule out this possibility. It contained a maximum at 346-348 nm
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with a shoulder at 420 nm characteristic of a TNBS modified amino group (Okuyama and 
Satake, 1964). The observation that S-TNP groups are unstable at alkaline pH and break 
down to form sulfhydryl groups provides further evidence that the inactivation at pH 9.2 is 
due to modification of an amino group.
In protection experiments, the protection afforded by shikimate alone 
against TNBS inactivation implies the formation of a enzyme-substrate complex. The 
maximum protection obtained in the presence of both shikimate and NADP+ would account 
for the formation of a strong enzyrae-coenzyme-substrate ternary complex.
ESMS data clearly indicated the stoichiometry of incorporation. The accuracy 
of the measured masses of the modified species highlights ESMS as a technique of high 
resolution. In >75% inactivated sample three lysines were modified, and in the presence of 
NADP+ and shikimate two of these three residues were protected suggesting that they were 
important residues involved in catalysis or binding.
Attempts to identify the two protected lysines by differential peptide mapping 
proved more difficult than anticipated. Appearance of the three modified lysines on a 
number of partial peptides as indicated by the HPLC trace at 346 and 420 nm and the 
disappearance of most of these peptides in the protected sample made identification of any 
two peptides corresponding to the protected residues difficult, Chymotrypsin specifically 
cleaves at the carboxyl terminal bonds of Phe, Tyr and Trp (Beynon and Bond, 1990) but 
with prolonged incubation, and upon complete opening of the structure following 
dénaturation large peptides may be secondarily cleaved to generate partial peptides. 
However the approach of LCMS to identify the three modified lysines by the increase in 
mass was straight forward and efficient. The modified lysines were identified as Lys-65, 
Lys-15 and Lys-217/219. The attachment of a TNP group delayed the retention time of the 
modified peptides by approximately 13 min compared with the native peptides. This is 
presumably due to the increased hydrophobicity caused by the TNP group. The two 
lysines protected by NADP+ and shikimate were identified as Lys-65 and Lys-15,
Although protection studies showed that two lysines were protected by substrate 
and coenzyme, kinetic data revealed that only one lysine was essential. This was in
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agreement with sequence data since Lys-65 is the only conserved lysine in all known 
SKDH sequences. From these results it can be reasonably concluded that Lys-65 is the 
essential lysine at the active site of E. coli SKDH.
In order to investigate a possible role for Lys-65 protection experiments were 
carried out using methyl shikimate, a substrate analogue of shikimate. Methyl shikimate 
was not able to afford any protection against TNBS inactivation, whereas shikimate in the 
same concentration afforded significant protection. These data clearly indicated that the £- 
amino group Lys-65 is involved in an ionic interaction with carboxylate group of shikimate.
This work has identified Lys-65 of E. coli SKDH as an essential residue at 
the binding site of shikimate. The identification of this residue opens the way for further 
experiments such as site-directed mutagenesis aimed more directly, at probing it's role.
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CHAPTER 5
A functional arginine residue at the coenzyme binding 
site of Escherichia coli shikimate dehydrogenase
5.1 Introduction
The guanidino group of arginine is highly basic and has been proposed to 
play an essential role in the active sites of enzymes binding anionic substrates and 
coenzymes (Riordan, 1979). The high pKa (-12-13) of the guanidino functional group 
necessitates alkaline reaction conditions to generate an effective nucleophile in chemical 
modification of arginine residues. However it had been shown that the pKa of arginyl 
residues at anion binding sites is lower than that of other arginine residues due to the strong 
electric potential of the anion binding sites (Patthy and Thesz, 1980) which would also 
explain their remarkable specificity towards dicarbonyl reagents used in chemical 
modification.
Within the family of pyridine nucleotide dependent dehydrogenases, many 
enzymes contain arginyl residues as components of their coenzyme binding sites; e.g. Arg- 
101 in dogfish M4 lactate dehydrogenase (Adams e ta l,  1973) and Arg-47 in horse liver 
alcohol dehydrogenase (Eklund e ta l, 1974). It has been shown by X-ray crystallographic 
studies that these arginine residues interact with the pyrophosphate moiety of NAD+ 
facilitating it's binding to the enzyme (Eklund et a l, 1974; Adams et a l, 1973). The 
guanidino group is ideally suited for interaction with phosphate by virtue of its coplanar 
structure brought about by the partial double bond character of each of the C-N bonds 
(Cotton e ta l,  1973). This unique chemistry enables the guanidino group to form multiple 
hydrogen bonds with phosphate thus highlighting a major biological function of arginine in 
interacting with phosphorylated metabolites (Riordan et a l, 1977).
In preliminary experiments treatment of SKDH with the arginine specific 
reagent phenyl glyoxal (PGO) resulted in a rapid loss of enzyme activity. NADP+ 
protected the enzyme effectively against inactivation but shikimate did not offer any 
protection. These observations led to the investigation of the involvement of arginine 
residue(s) at the coenzyme binding site of SKDH, firstly to provide further evidence for the 
view that arginine residues are generally involved in coenzyme binding in the pyridine 
nucleotide-dependent dehydrogenases and secondly to locate the particular arginines 
involved.
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Fig. 5.1 Reaction of phenyiglyoxal with arginine residues in proteins
5.2 Chemical modification of arginine with Phenyiglyoxal (PGO)
5.2.1 Background
PGO was first introduced by Takahashi in 1968 as a reagent to react with 
guanidino groups of arginine under müd conditions (pH 7-8) to give a product that contains 
two PGO moieties per guanidino group (Takahashi, 1968). This product is relatively stable 
at acidic pH's and dissociates to regenerate arginine on prolonged incubation in neutral and 
alkaline media.
PGO also reacts with a-amino groups with a significant rate, probably via 
Schiff base formation followed by transamination, to give a-keto acyl derivatives. Upon 
prolonged treatment with high concentrations of PGO e-amino groups may also react 
(Takahashi, 1968). The reaction of arginine with PGO is pH dependent and is greatly 
accelerated in bicarbonate-carbonate buffer systems (Cheung and Fonda, 1979). The 
specific effect of bicarbonate is thought to be due to complex formation between 
bicarbonate and the guanidino group, which lowers the pKa and thus promotes nucleophilic 
attack by the guanidino group at the carbonyl carbon of phenyiglyoxal (Riordan, 1979).
The stoichiometry of the reaction between PGO and arginine has been 
variable in different cases studied. It has been quoted as 2:1 (Takahashi, 1968; Lange et. 
a l,  1974) or 1:1 (Borders and Riordan, 1975; McKee and Nimmo, 1989) and has been 
suggested to depend on the microenvironment of the arginine residue involved (Riordan, 
1979; Borders and Riordan, 1975). However more recent work, done using electrospray 
mass spectrometry to monitor PGO modification by measuring the increase in mass has 
illustrated that initial PGO modification leads to the formation of a 1:1 adduct which can 
very rapidly dehydrate to form a stable product or react with a second PGO molecule to 
form a 2:1 adduct (Krell et a l, 1995). This reaction scheme is shown in Fig. 5.1.
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5.2.2 Kinetics of PGO modification of SKDH
Treatment of E.coli SKDH with PGO at 25°C caused a time-dependent loss 
of enzyme activity. The inactivation became more rapid as the pH was increased and a pH 
of 9.4 in sodium carbonate-bicarbonate buffer was adopted for further study. In the control 
experiment SKDH was incubated in the absence of PGO and no loss of activity was 
detected. The fraction of activity remaining was calculated as the percentage of activity 
remaining at a given time. The plot of logarithm of percent activity remaining against time at 
various PGO concentrations yielded straight lines indicating that the inactivation followed 
pseudo first-order kinetics (Fig. 5.2 A). The rate of inactivation was dependent on reagent 
concentration. The t i /2 values and pseudo first-order rate constants (kobs) for the 
inactivation process are summarized in table 5.1. Treatment of kinetic data and calculation 
of pseudo first-order rate constants were done as described in section 4.2.2.
Table 5.1
Half life ( t i /2) and pseudo first-order rate constants ( k o b s )  for the 
inactivation of SKDH at different concentrations of PGO
[PGO] m M t i / 2  m i n k o b s / m i n
0.50 99.5 0.007
1.00 22.4 0.031
1.50 14.8 0.047
2.00 11.1 0.062
2.50 7.3 0.095
3.00 5.3 0.131
________
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Fig 5.2 Kinetics of inactivation of SKDH by PGO 
Fig 5.2 A. Pseudo first-order plots for inactivation
SKDH (2-3 |xM) was incubated with increasing concentrations of PGO in 100 mM 
sodium bicarbonate-carbonate buffer, pH 9.4 at 25°C. Aliquots were removed at time 
intervals and were assayed for residual enzyme activity as described in section 3.4. The 
concentrations of PGO used were 0.5 mM(B), 1.0 mM(f), 1.5 mM(n), 2.0 mM(^), 2.5 
mM(«) and 3,0 mM(p).
Fig 5.2 B Relationship between pseudo first-order rate constants and PGO 
concentration
Pseudo first-order rate constants calculated in part A were plotted against PGO 
concentration (o) or the square of PGO concentration (•). These data indicate that the 
reaction is second-order with respect to PGO.
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Fig. 5.2 C Determination of the order of the reaction
A plot of log (pseudo first-order rate constants) against log (PGO concentration) yielded a 
straight line with a slope of 1.7 indicating that approximately two molecules of PGO are 
needed to inactivate the enzyme.
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A plot of pseudo first-order rate constants against PGO concentration is 
markedly nonlinear (Fig. 5.2 B). However if the data are replotted by using the square of 
the PGO concentration a straight line is obtained (Fig. 5.2 B). This indicates that the 
inactivation is first order with respect to enzyme and second-order with respect to PGO. 
Similar observations have been reported for L-lactate monooxygenases (Peters et a/., 1981; 
Soon e ta l,  1978).
Consistent with this is the kinetic order calculated using equation (7) in 
section 4.2.2. A plot of log kobs against log [PGO] yielded a straight line with a slope of 
1.7 (Fig. 5.2 C), indicating that two molecules of PGO are needed to inactivate a single 
molecule of active enzyme unit (Levy et a l, 1963).
5.2.3 Substrate protection against PGO inactivation
Incubation of SKDH with PGO in the presence of shüdmate and NADP+ 
resulted in the retention of enzyme activity (Fig. 5,3) indicating that PGO is reacting with a 
arginine(s) at or near the active site. The percentages of protection afforded were calculated 
as described in section 4.2.3. Shikimate alone afforded 12% protection whereas NADP+ 
alone increased this to a significant 78%. However in the presence of both shikimate and 
NADP+ this was slightly increased to 81%.
These data indicate that NADP+ protects the enzyme against PGO 
inactivation effectively and therefore PGO appears to be reacting with an arginine or 
arginines involved in binding of NADP+ to the enzyme. This is in good agreement with 
other pyridine nucleotide dependent dehydrogenases where functional arginines are found 
at coenzyme binding sites (Adams et a l, 1973; Eklund et a l, 1974). The protection 
afforded by shüdmate, alone or with NADP+ is insignificant and may provide evidence to 
rule out the possibility of arginine residues being involved in shikimate binding or 
catalysis.
______________
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Fig. 5.3 Substrate and coenzyme protection against PGO inactivation
SKDH was incubated with 2.2 mM PGO alone(O), or in the presence of 0.4 mM 
shikimate(4 ), or 0.2 mM NADP+(b) or a mixture of 0.4 mM shikimate and 0.2 mW 
NADP+f^). This figure indicates the protection afforded by NADP"^ against PGO 
inactivation.
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5.2.4 Stoichiometry of incorporation of PGO into SKDH
The incorporation of PGO into SKDH was determined using samples 
inactivated to different extents, prepared as described in section 3,7.3. The samples were 
analysed by ESMS in the positive ion mode as described in section 3.6.5 and quantitative 
analysis of raw data was done using the MaxEnt deconvolution procedure with 1.0 Da peak 
width and 1.0 Da channel resolution ( Ferridge et a l, 1992).
The extent of incorporation proceeded in parallel with the loss of activity. In 
the ESMS profile of the 90% active sample (Fig. 5.4 A) the major peak was of unmodified 
enzyme with a molecular mass of 29,414 Da and the only significant modified species had 
a mass of 29,530 Da which indicated a mass difference of +116. Incorporation of one PGO 
per arginine with the loss of water would result in a mass difference of +116 (Krell et a l, 
1995), therefore this peak corresponds to enzyme species with one arginine residue 
modified.
In the sample that was 60% active the two major peaks related to the 
unmodified enzyme and to the +116 species. These data suggested that the initial 
inactivation of the enzyme was due to the modification of one arginine residue, which 
forms a simple 1:1 adduct with PGO, followed by dehydration. Two other minor modified 
species were also present with molecular masses of 29,664 Da and 29,646 Da, These 
relate to species with mass difference of +250 corresponding to the Takahashi adduct with 
two PGO's per arginine and +232 corresponding to two different arginines each modified 
with a single PGO molecule. The electrospray profile of the 60% active sample is shown in 
Fig. 5.4 B.
The 35% active sample was extensively modified and a small percentage of 
unmodified enzyme remained (Fig. 5.4 C). The more significant modified species had 
molecular masses of 29530, 29646, 29664, 29780, 29896, 29914, 30012 and 30030 Da 
corresponding to mass differences of +116, +232, +250, +366 (250 plus 116), +482 (250 
plus 116x2), +500 (250x2), +598( 250 plus 116x3) and +616(250x2 plus 116) 
respectively. These data indicate that in extensively modified enzyme the modified arginines 
could have both 1:1 and 2:1 stoichiometry, and this is in good agreement with the reaction
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Fig. 5.4 Electrospray mass spectrometry of PGO modified SKDH
Fig. 5.4 A. ESMS profile of the 90% active SKDH showed a major peak with a 
molecular mass of 29,414 Da relating to unmodified enzyme (E) and another peak with a 
+116 mass difference (29,530 Da) indicative of enzyme species with one modified 
arginine with a single PGO molecule with loss of water.
Fig. 5.4 B The 60% active sample showed two main peaks due to unmodified enzyme 
(E) (29,414 Da) and +116 species (29,530 Da). Minor modified species with mass 
differences of +232 (29,646 Da) and +250 (29,664 Da) corresponding to two modified 
arginines with a single PGO each and the Takahashi adduct of one modified arginine with 
two PGO's were also present.
100-1
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Fig. 5.4 C ESMS profile of the 35% active sample (treated with 3.0 mM PGO in the 
absence of NADP+) showed a number of modified species with mass differences of +116, 
+232, +250, +366 (116 plus 250), +482 (116x2 plus 250), +500 (250x2), +598 (116x3 
plus 250) and +616 (116 plus 250x2).
Fig. 5.4 D ESMS profile of the NADP+ protected sample (treated with 3.0 mM PGO in 
the presence of 2.0 mM NADP+) showed significant protection indicated by the decrease 
in the number of modified species. The main peaks were of unmodified enzyme (E) 
(29,414 Da) and modified species with mass differences of +116, +250 and +366 (116 
plus 250).
+250 +366100-1 +232+116
+500
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+116100-1
+250
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scheme reported by Krell et a l (1995). However, due to the variable stoichiometry and the 
relatively low stability of the PGO adduct determination of the number of arginines 
modified in this sample proved difficult.
In the presence of NADP+ the sample was 93% active although the same 
amount of PGO was used as in the 35% active sample. The ESMS profile of this sample 
(Fig. 5.4 D) had a major peak corresponding to the unmodified enzyme and three other 
peaks corresponding to modified species. These peaks had molecular masses of 29530, 
29664 and 29780 Da, corresponding to mass differences of +116, +250 and +366 (250 
plus 116) respectively. Accordingly, in the presence of NADP+ the number of modified 
species was greatly reduced and binding of NADP+ to the enzyme had protected one or 
more arginines from PGO modification. The protected arginine(s) could be functionally 
important in the binding of the coenzyme.
5.3 Differential peptide mapping of PGO modified SKDH by RP-HPLC
In order to identify peptide(s) containing arginine(s) protected by NADP+, 
differential peptide mapping of PGO modified SKDH in the absence and presence of 
NADP+ was attempted. Detailed comparison of the peptide maps at 214 nm would allow 
the identification of regions protected by NADP+ from PGO modification.
Differential peptide mapping was performed using the tryptic digests of 
SKDH modified with 3.0 mM PGO in the presence and absence of 2.0 mM NADP+. 
Preparation and proteolysis of the samples are described in sections 3,7.3 and 3.7.5 
respectively. Samples were fractionated using a Vydac 214TP C4 column and peptides 
were eluted with a split acetonitrile gradient as described in section 3.7.6. Detailed 
inspection of the peptide maps at 214 nm of PGO modified SKDH in the absence of 
NADP+ (Fig. 5.5.A) and in the presence of NADP+ (Fig. 5.5.B) showed that the peptide 
maps were identical except for one protected peptide. This peptide clearly eluting after 
approximately 21.2 minutes, was present in the sample modified in the absence of NADP+ 
and was absent in the protected sample. It therefore seemed likely that this was an active 
site peptide containing a functional arginine. This difference in profiles observed at 21.2
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Fig. 5.5 Differential peptide mapping by RP-HPLC
HPLC profiles of tryptic digests of PGO modified SKDH in the absence (A) and 
presence (B) of NADP+
Experimental details are given in section 3.7.6. Identical quantities of protein were 
injected (80 fig) and the peptide maps were monitored at 214 nm, the common wave 
length for the detection of peptides. The peptide maps were identical except for one 
peptide which had a retention time of 21.2 min designated as X(+) in profile A and X(-) 
in profile B. mAbs represents miUi absorbance units.
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minutes was highly reproducible between separate experiments.
5.4 Identification of NADP+ protected peptide by LCMS
To identify the peptide protected by NADP+, and hence the functional 
arginine the preferred technique was LCMS as described by Krell et a l (1995) for simple 
and rapid identification of PGO modified peptides in the type H dehydroquinases.
Tryptic digests of SKDH modified with PGO in the absence and presence 
of NADP+ (different aliquots of the samples used in section 5.3) were analysed using 
LCMS as described in section 3.7.7 and the peptides were scanned for an added mass of 
116 and 250. In the unprotected sample two peptides with +116 mass units were identified. 
These peptides are referred to as T1 and T2 (Table 5.2). However, at this stage detection of 
peptides with a mass of +250 proved difficult possibly due to the instability of the +250 
adduct (Takahashi, 1968) during the prolonged incubation at alkaline pH required for 
proteolysis. The HPLC trace and the mass scans of the doubly charged ions of peptides 
Tl+116 and T2+116 are shown in Fig. 5.6.1 A-C respectively.
Table 5.2
Peptide Sequence M+2H/2 Da
T1 151t VSRA EELAK160 610.63
T2 79aALAG AVNTL MRLED GR^5 938.02
(M= Mass of peptide+116, H=1.00 Da)
Trypsin is a highly specific protease which cleaves at the carboxy group of 
Lys and Arg (Beynon and Bond, 1989) and the modification of either of these residues 
should lead to the loss of trypsin sensitive sites. Similar observations of loss of trypsin 
sensitive sites following modification of lysine have been reported by Xia et a l (1993).
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Fig. 5.6.1 LCMS of PGO modified SKDH in the absence of NADP+
Experimental details are given in section 3.7.7. HPLC trace (at 214 nm) of the tryptic 
digest of PGO modified SKDH in the absence of NADP+ (A), mass scans of the doubly 
charged ions of peptides Tl+116 (B) and T2+116 (C) which resulted in the identification 
of Arg-154 and Arg-90 as the modified arginines in peptides T1 and T2 respectively.
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Fig. 5.6.2 LCMS of PGO modified SKDH in the presence of NADP+
HPLC trace (at 214 nm) of the tryptic digest of PGO modified SKDH in the presence of 
NADP+ (A), mass scans of the doubly charged ions of peptides Tl+116 (B) and T2+116 
(C). Absence of a peak in the mass scan for Tl+116 indicate that Arg-154 is completely 
protected from PGO modification in the presence of NADP+.
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Therefore, Arg-154 and Arg-90 can be confirmed as the sites of modification in peptides 
T1 and T2 respectively.
Mass scans following LCMS of the protected sample showed that in the 
presence of NADP+, Arg-90 in peptide T2 is still accessible to PGO. However, no peak 
was obtained for the mass of Tl+116 indicating that Arg-154 is completely protected by 
NADP+ from PGO modification. The HPLC trace of the protected sample and the mass 
scans of the doubly charged ions of peptides Tl+116 and T2+116 are shown in Fig. 5.6.2 
A-C. Comparison of LCMS data with differential peptide mapping data in section 5.3, 
showed that the NADP+ protected peptide with a retention time of 21.2 minutes, was the 
same peptide as peptide T l. Accordingly, it can be concluded that in the presence of 
NADP+ Arg-154 is completely protected from PGO modification.
5.5 The role of Arg-154
The structural properties of the guanidino group of arginine residues enables 
multiple hydrogen bond formation with phosphate groups (Cotton et a l , 1973). In NAD+ 
and NADP+, the pyrophosphate group which bridges the nicotinamide and the adenosine 
moieties of the molecule provides an excellent site for such hydrogen bond formation. This 
is best illustrated in dogfish M4 LDH and LADH, where Arg-101 and Arg-47 respectively, 
are hydrogen bonded to the pyrophosphate group of NAD+ (Adams et a l, 1974; Eklund et 
a l, 1974), However, in NADP+ there is an additional phosphate group at the 2’ position 
of the adenosine moiety which can also be hydrogen bonded with an arginine residue. In 
human glutathione reductase Arg-218 and Arg-224 interact with this T  phosphate group 
and this has been shown to confer specificity for NADP+ (Scrutton et a l, 1990). Also in 
NADP-dependent cytoplasmic malate dehydrogenases arginine residues facilitate the 
binding of the 2’ phosphate group of the adenine ribose (Nishiyama et a l, 1993).
In order to investigate whether Arg-154 of SKDH is interacting with the 2' 
phosphate of the adenine ribose, protection experiments were repeated with NAD+. SKDH 
binds with NAD+ but activity is ten fold less than with NADP+ perhaps because NAD+ 
lacks the 2' phosphate group. However, in the presence of NAD+ no protection was
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Fig 5.7 Protection against PGO inactivation with NAD+ and NADP+.
SKDH was incubated with 3.0 mM PGO alone (q), or in the presence of 0.2 mM NAD+ 
(♦), or 0.2 mMNADP+(P)
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obtained against PGO inactivation whereas, the same concentration of NADP+ afforded 
strong protection (Fig. 5.7). This suggest that Arg-154 is not interacting with the 
pyrophosphate bridge of the ADP moiety; instead it appears likely that Arg-154 of E. coli 
SKDH interacts with the phosphate group at the 2' position of the adenosine moiety of 
NADP+.
5 .6  A c tiv e  s i te  h o m o lo g y
The present investigation led to the identification of Arg-154 as a component 
of the coenzyme binding site of E. coli SKDH. Comparison of amino acid sequence 
around Arg-154 with matching SKDH sequences from other organisms showed that Arg- 
154 is conserved in N.tabacum, substituted by Lys in four other sequences {P. aeruginosa, 
A. nidulans, S. cerevisiae and Pxarinii ) and by Asn in B. aphidicola sequence (Fig. 5.8). 
A common feature of Arg, Lys and Asn is they all contain -NH2 groups which are capable 
of hydrogen bond formation. Although the involvement of arginine and lysine residues in 
hydrogen bond formation are well known, many cases have been reported where Asn 
residues are also involved in hydrogen bond formation, such as Asn-240 of Clostridium 
symbiosum glutamate dehydrogenase and Asn-160 of human aldose reductase (Baker et 
a i, 1992; Wilson et a l, 1992). Therefore it is reasonable to infer from these data that the 
residue equivalent to Arg-154 in the E. coli sequence is a functionally conserved residue 
involved in a hydrogen bonding interaction with the 2 ' phosphate of the adenosine ribose 
ofNADP+.
5 .7  D is c u s s io n
Arginines play an important role in biological systems in interacting with 
phosphorylated metabolites. This is best illustrated in the glycolytic pathway, where all of 
the intermediates are esters of phosphoric acid and all but one of the glycolytic enzymes 
contain essential arginine residues at their active sites (Riordan et a l, 1977). A similar 
observation is found in pgridine nucleotide-dependent enzymes, where functional arginines 
are found at coenzyme binding sites. The present work was based on this observation.
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PGO is a dicarbonyl reagent commonly used in selective modification of 
arginines, but it can also react with a-amino groups (Takahashi, 1968; Lundblad and 
Noyes, 1984). It had been reported that functional arginines have lower pKa values than 
other arginines due to the strong positive electric potential of the anion binding sites (Patthy 
and Thesz, 1980). Thus functional arginines are hyper-reactive and can be modified 
selectively thereby facilitating structure-function correlation. Incubation of SKDH with 
PGO resulted in the inactivation of the enzyme in a pseudo first-order fashion. Analysis of 
kinetic data revealed that the reaction is first order with respect to enzyme and second-order 
with respect to PGO. This suggested that the inactivation of the enzyme could result either 
from modification of one essential arginine with two PGO's or from modification of two 
essential arginines with a single PGO each. However, a possible explanation for this could 
be obtained through ESMS data. The 90% active sample revealed only one modified 
species with a mass difference of +116 relating to one arginine residue modified with a 
single PGO with loss of water. In the 60% active sample this modified species was more 
significant indicating that initial inactivation of the enzyme was due to the modification of 
one arginine. Therefore it seems likely that there is only one essential arginine which forms 
a 1:1 intermediate initially with PGO which rapidly dehydrates to form a stable product.
This is in good agreement with the reaction scheme reported by Krell et a l (1995). Also, 
according to this scheme the initial 1:1 intermediate could react with a second PGO 
molecule to form a 2:1 adduct. Therefore a modified arginine could have both 1:1 and 2:1 
stoichiometry. This is clearly indicated in the ESMS profile of the 35% active sample where 
both adducts of modified arginines are revealed. However, the bulky nature of the PGO 
molecule could cause the addition of a second PGO to the initial intermediate to be rate 
limiting, leading to an inactivation which is second-order in PGO (Peters et a l, 1981). The 
appearance of a minor peak for +250 mass units (2:1 adduct) in the 60% active sample 
may strengthen the above argument.
PGO modification in the presence of NADP+ resulted in the retention of 
most of the enzyme activity. ESMS data of the NADP+ protected sample showed a 
significant reduction of the number of modified species providing evidence for the
9 6
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protection afforded by NADP+. These data suggested the involvement of at least one 
functional arginine in NADP- binding. Having inferred this, their identification using 
differential peptide mapping and LCMS was attempted.
In a control experiment, a tryptic digest of unmodified (native) SKDH was 
analysed using LCMS. There are thirteen arginines in the SKDH sequence, and they 
should be located on twelve peptides in a tryptic digest since trypsin is insensitive to sites 
between Arg-Pro. Six of these arginine containing peptides were identified in the native 
digest but detection of the other smaller peptides proved difficult possibly due to their weak 
binding. LCMS of tryptic digests of PGO modified SKDH in the absence and presence of 
NADP+ resulted in the identification of Arg-154 as a NADP+ protected arginine. 
Furthermore, LCMS of a tryptic digest of the 90% active sample (in which only one 
arginine is modified) led to the identification of Arg-154 as the modified arginine, 
confirming that it is the primary site of modification. Thus Arg-154 is clearly hyper-reactive 
and has a functional role as has been shown for other hyper-reactive arginines ( Patthy and 
Thesz, 1980). Based on the results of the protection experiment with NAD+, it appears that 
this arginine is involved in binding of the 2 ' phosphate group of the adenine ribose.
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CHAPTER 6
Involvement of a Histidine residue 
as a general acid/base in the catalytic mechanism of 
Escherichia coli shikimate dehydrogenase
_______________ _
6.1 Introduction
The role of histidine residues as general acid/base catalysts in enzyme 
mechanisms depends upon the special features of the imidazole group. It is a flat 
heterocyclic molecule structurally related to both pyrrole and pyridine and has a pKa of~7.0 
(Schneider, 1978). Donor and acceptor properties are thus combined in imidazole at neutial 
pH making it an optimal catalyst and a buffer in biological systems (Eigen, 1964).
A large number of enzymes contain essential histidine residues at their active 
sites. For example, in the hydrolysis of RNA by bovine pancreatic ribonuclease, His-12 
and His-119 are involved in donation and abstraction of protons (Richards and Wyckoff, 
1971; Fersht, 1985) and the conversion of pyruvate to lactate is facilitated by the donation 
of a proton from His-195 in dogfish M4 lactate dehydrogenase (Adams et a l, 1970). The 
histidine in the catalytic triad of serine proteases abstracts a proton from a serine residue 
and enhances the nucleophilicity of the oxyanion to attack the carbonyl carbon of the 
peptide bond (Kraut, 1977; Warshel et a l, 1989). In the active site of the zinc protease 
carboxypeptidase A the imidazole groups of His-196 and His-69 serve as ligands for the 
binding of zinc atom which is essential for activity (Lipscomb, 1973). Histidine residues 
also participate in binding of substrates via hydrogen bonding and/or electrostatic 
interactions as in the case of carbamoyl phosphate synthetase in which His-312 is involved 
in the binding of glutamine (Miran et al, 1991).
The role of His-195 in proton transfer in lactate dehydrogenase is shown in 
Fig. 6.1. The first direct evidence for this role for histidine was obtained using chemical 
modification with the histidine specific reagent diethylpyrocarbonate (DEPC) (Holbrook 
and Ingram, 1973). The involvement of a histidine residue in proton transfer is thought to 
be a general feature of pyridine nucleotide dependent dehydrogenases (Price and Stevens, 
1989). Thus, it was expected that a histidine side chain would be involved as a general 
acid/base in the catalytic mechanism of E. coli SKDH. In preliminary experiments it was 
observed that E. coli SKDH could be rapidly inactivated by DEPC (R. Syme and J.R. 
Coggins, unpublished data). The present chapter confirms and extends this work and 
describes attempts to identify the particular histidine involved.
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6.2 Chemical modification with diethylpyrocarbonate (DEPC)
6.2.1 Background
DEPC has proven to be the most commonly used reagent for selective 
modification of histidine residues in proteins (Lundblad and Noyes, 1984). Until the 
development of this reagent photo-oxidation techniques were used for histidine 
modification but problems persisted with specificity; methionine, tryptophan, tyrosine, 
serine and threonine were also sensitive to photo-oxidation in somewhat different extents 
(Ray and Koshland, 1962). DEPC is specific for reaction with imidazole groups of 
histidine residues within the pH range 5.5 to 7.5 (Lundblad and Noyes, 1984). The 
reaction yields an N  -carbethoxyhistidine derivative, due to the substitution at one of the 
nitrogen positions of the imidazole ring (Fig. 6.2 A). This derivative has an absorption 
maximum between 230-250 nm, and the number of modified histidine residues can be 
calculated from the molar absorption difference (Ae240= 3200 cm-^)( Miles, 1977).
The reaction can be reversed by addition of hydroxylamine which removes the carbethoxy 
group and regenerates histidine (Fig. 6.2 B)(Miles, 1977). In the presence of excess DEPC 
disubstitution of the imidazole ring may result in a derivative which has an absorption 
maximum between 220-240 nm, and the treatment of this derivative with hydroxylamine 
does not regenerate histidine but results in the scission of the imidazole ring (Miles, 1977).
DEPC can also react with other nucleophiles such as cysteine, tyrosine and 
primary amino groups (Muhlrad et a l, 1967) in proteins. Modification of sulfhydryl 
residues, although not well documented with protein bound cysteines can be determined by 
a decrease in free sulfhydryl groups (Lundblad and Noyes, 1984) and O-carbethoxylation 
of tyrosine residues can be detected by a decrease in absorbance at 278 nm (Burstein et al,
1974). O-carbethoxylation can be slowly reversed by treatment with hydroxylamine 
(Melchior and Fahmey, 1970) but the reaction with primary amino groups yields a 
derivative which is stable to hydroxylamine (Lundblad and Noyes, 1984). Therefore in the 
modification of histidine residues with DEPC the possibility of these side reactions should 
not be ruled out without investigation.
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6.2.2 Kinetics of DEPC inactivation of SKDH
Incubation of SKDH with DEPC in 50 mM sodium phosphate buffer, pH
7.0 at 25°C resulted in a rapid loss of enzyme activity. In the control experiment, in the 
absence of DEPC, no loss of activity was detected. The fraction of activity remaining was 
calculated as a percentage and plots of logarithm of percent activity remaining against time 
at various DEPC concentrations were linear (Fig. 6.3 A) indicating that the inactivation 
followed pseudo first-order kinetics. It was evident that the rate of inactivation was 
dependent on reagent concentration. Treatment of kinetic data and calculation of pseudo- 
first order rate constants were done as described in section 4.2.2, The half life values and 
the pseudo first-order rate constants for the inactivation process are summarised in Table 
6 . 1 .
Table 6.1
Half life { t m )  and pseudo first-order rate constants (kobs) for the 
inactivation of SKDH at different DEPC concentrations
[DEPC] mM ti /2 (min) kobs/n iin
0 .3 25.1 0.028
0.5 8.5 0.082
0.8 6.5 0.107
1.0 5.3 0.130
1.2 3.9 0.178
1.5 3.1 0.226
The second-order rate constant calculated from a plot of pseudo first-order rate constants 
against DEPC concentration (Fig.6.3 B) was 154 M-lmin-1. The order of the reaction with 
respect to DEPC calculated from a plot of log kobs against log [DEPC] (using equation 7 in
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Fig. 6.3 Kinetics of inactivation of SKDH with DEPC 
Fig. 6.3 A Pseudo first-order plots for inactivation
SKDH (2-3 |iM) was incubated with increasing concentrations of DEPC in 50 mM 
sodium phosphate buffer, pH 7.0 at 25°C. Aliquots were removed from the reaction 
mixture at time intervals, quenched in imidazole and assayed for residual activity. 
Experimental details are given in section 3.8.2. The concentrations of DEPC used were 
0.3 mM(0 ), 0.5 mM(4 ), 0.8mM(n), 1.0mM(4), 1.2mM(m) and 1.5mM(o).
Fig. 6.3 B Determination of the second-order rate constant of inactivation
Pseudo first-order rate constants calculated in part A were replotted against DEPC 
concentration, and the second-order rate constant was calculated to be 154 M’^min'^ from 
the slope.
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Fig 6.3 C Determination of the order of the reaction
The order of reaction with respect to DEPC was calculated from a plot of log (pseudo first- 
order rate constant) against log (DEPC concentration). The slope of this plot was calculated 
to be 1.14 indicating that the modification of a single histidine residue inactivated the 
enzyme.
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section 4.2.2) was 1.14 indicating that modification of one essential histidine by DEPC 
results in the inactivation of the enzyme (Fig. 6.3 C).
6.2.3 Substrate protection against DEPC inactivation
Incubation of SKDH with DEPC in the presence of shikimate and NADP+ 
resulted in the retention of enzyme activity (Fig. 6.4) suggesting that the inactivation was 
active site directed. The percentages of protection afforded were calculated using the 
equation in section 4.2.3. Shikimate alone afforded 54% protection whereas NADP+ alone 
afforded 58% protection against DEPC inactivation. A maximum protection of 75% was 
obtained in the presence of both NADP+ and shikimate. The protection afforded by 
shikimate was enhanced in the presence of NADP+ and a similar observation was made in 
protection experiments against TNBS (section 4.2.3). According to these data, it appears 
that the proper binding of shikimate to the enzyme occurs only in the presence of the 
coenzyme. Thus shikimate alone is not able to afford good protection for residues involved 
in its binding or catalysis.
The protection afforded by shikimate and NADP+ together against 
inactivation indicate that the essential histidine is protected from acylation when the enzyme 
is complexed with shikimate and NADP+. In many dehydrogenases substrate reduction is 
facilitated by the transfer of a proton from an imidazole group of a histidine residue and a 
hydride ion from NAD(P)H (Fig. 6.1). In view of this and the nature of the protection 
afforded, it can be proposed that the essential histidine is involved in the proton transfer 
step of the oxidation of shikimate.
6.2.4 Characterisation of DEPC modified SKDH
DEPC reacts with cysteines, tyrosines and lysines in addition to histidines 
(Muhlard et a l, 1967). In order to investigate this possibility, characterisation of the 
reaction of DEPC with SKDH was attempted.
The difference absorption spectrum of DEPC modified SKDH recorded 
against unmodified SKDH revealed an absorption maximum at 240 nm (Fig. 6.5) which is
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Fig 6.4 Substrate and coenzyme protection against DEPC inactivation
SKDH (2-3 |o.M) was incubated with LO mM DEPC in 50 mM sodium phosphate buffer, 
pH 7.0 at 25°C alone (m), or in the presence of 4.0 mM shikimate ($), or 4.0 mm NADP+ 
(d) or a mixture of both in 4.0 mM concentration (4 ). This figure indicates that maximum 
protection is obtained when shikimate and NADP+ are both present in mixture.
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characteristic of the carbéthoxylation of histidine residues (Ovadi et a l, 1967; Miles, 
1977). The magnitude of the maximum increased with incubation time indicating time 
dependent carbéthoxylation. Upon addition of neutral hydroxylamine to the reaction 
mixture a decrease in the maximum was detected indicating decarbethoxylation. This 
provided evidence for the reaction of DEPC with histidine. However, O-carbethoxylation 
of tyrosine residues can also be reversed by treatment with hydroxylamine but the complete 
absence of spectral change at 278 nm ruled out the possible formation of O- 
carbethoxytyrosine, which would be characterised by a decrease in the difference spectrum 
at 278 nm (Ae278=1310 M-lcm-l)(Burstein e ta l, 1974),
6.2.5 Correlation of activity with carbéthoxylation and decarbethoxylation 
reaction
The extent of carbéthoxylation was related to inactivation of SKDH by 
monitoring the activity during the reaction. With the increase in absorbance at 240 nm a 
concomitant decrease in activity was detected (Fig 6.6 A). This indicated that the 
inactivation of the enzyme was due to the carbéthoxylation of histidine residues. The 
number of histidine residues modified were calculated from the extinction coefficient for 
carbethoxyhistidine (Ae240=3200 M-  ^cm-l) and complete inactivation correlated with the 
modification of approximately seven histidine residues (Fig. 6.6 B). These data suggested 
that both essential and nonessential histidine residues were being modified by DEPC.
Hydroxylamine treatment resulted in a decrease in absorbance at 240 nm 
and restoration of enzyme activity (Fig. 6.6 A). This indicated the regeneration of histidine 
residues following decarbethoxylation. However, complete restoration of activity was not 
possible, even after prolonged incubation. According to Miles (1977), the failure of 
hydroxylamine to fully reactivate a modified enzyme implies either, modification of other 
residues, for example lysine residues which are important for the activity or conformation 
of the enzyme, or the reaction of two equivalents of DEPC with one equivalent of histidine 
followed by a Bamberger reaction to open the imidazole ring. The latter can be ruled out as 
there is no marked increase in absorbance in the 230-250 nm region during hydroxylamine
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Fig. 6.5 Difference absorption spectra of DEPC modified SKDH
Difference absorption spectra of DEPC modified SKDH were recorded against unmodified 
SKDH, The absorption maximum at 240 nm is indicative of N-carbethoxyhistidine 
(Ae24o=3200 M 'l cm~ ;^ Miles, 1977). The increase in the maximum at 240 nm relates to 
spectra recorded at 2min, 5 rain, 10 min and 15 min after the addition of DEPC, A28O 
absorbance of unmodified SKDH(......) and modified SKDH ( ____ ) are also shown.
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Fig. 6.6 A Correlation of activity with carbéthoxylation and decarbethoxylation
With the increase in absorbance at 240 nm ( o ) a concomitant decrease in SKDH activity 
( •  ) was detected indicating that inactivation of the enzyme was due to carbéthoxylation 
of histidine residues. Addition of 25 mM neutral hydroxylamine to the reaction mixture 
resulted in partial restoration of enzyme activity and the recovery of most of the initial 
absorbance at 240 nm.
Fig.6.6 B Relationship between remaining activity and the number of histidine 
residues modified
The number of histidine residues modified were calculated from A240 (Ae240=3200 M"  ^
cm’l; Miles, 1977) and were plotted against remaining activity. Extrapolation of the plot 
to zero activity correlated to the modification of approximately seven residues. Data were 
taken from A.
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treatment characteristic of the Bamberger reaction (Loosemore and Pratt, 1976). Further 
evidence to rule out disubstitution of the imidazole group during inactivation was obtained 
from the ESMS data presented in section 6.2,7. SKDH has an essential lysine at the active 
site (identified as Lys-65 in chapter 4) but carbéthoxylation of this amino group is unlikely 
since e-amino groups are less effective nucleophiles at neutral pH than imidazole groups 
and their reaction with DEPC is reported to be very slow (Wells, 1973; Church et a l, 
1985). Alternatively the partial recovery of activity may be due to irreversible dénaturation 
of the enzyme by hydroxylamine, and this notion is supported further by the recovery of 
most of the initial absorbance at 240 nm (Fig. 6.6 A). Similar observations have been 
reported by Badet and Badet (1992) with E. coli glucosamine-6-phosphate synthase.
6.2.6 pH dependence of DEPC inactivation
The pH dependence of inactivation can provide useful information about the 
pKa value of the modified residues (Takeuchi et a/., 1986). DEPC is known to react only 
with the unprotonated form of the imidazole group of histidine residues (Holbrook and 
Ingram, 1973). The apparent pKa of the essential histidine residue at the active site of 
SKDH was determined by following the pH dependence of the pseudo first-order rate 
constant for DEPC inactivation in phosphate buffer. The relationship between the pseudo 
first-order rate constant and pH can be expressed as,
kobs = (kobs)max / [l+(H+)/Ka]
which in linear form becomes,
kobsCH"*") = Ka(kobs)max - Kakobs
where Ka is the dissociation constant of the reacting group and (kobs)max is the pseudo 
first-order rate constant of the unprotonated reacting group (Takeuchi e ta l,  1986). A plot 
of kobs(H+) against kobs yielded a straight line (Fig 6.7); the (kobs)max calculated from
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Fig. 6.7 pH dependence of DEPC inactivation
SKDH was inactivated with DEPC over the pH range 5.5-7.1. The kobs values were 
calculated from pseudo first-order plots at various pH values and were plotted against 
kobs[H+]. The pKa of the reacting group calculated from the slope is 6 .6 .
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the ordinate intercept was 0.392 min"l and the pKa of the reacting group was calculated to 
be 6.6 from the slope. This is a typical pKa for a histidine residue (Cosineau and Meighen, 
1976; Holbrook and Ingram, 1973) and provides further evidence that DEPC inactivation 
of SKDH was due to the modification of a histidine residue.
6.2.7 Determination of the stoichiometry of incorporation of DEPC
The stoichiometry of incorporation of DEPC into SKDH in the absence and 
presence of protecting ligands was determined by ESMS in the positive ion mode as 
described in section 3.6.5. Preparation of unprotected and protected samples is described in 
section 3.8.6.
There are eight histidine residues in the primary sequence of SKDH and in 
the unprotected sample which was >70% inactivated, seven of these residues were 
modified (Fig. 6.8 A). The absence of a peak corresponding to unmodified enzyme, 
although the sample was not completely inactivated, indicated the modification of both 
essential and nonessential residues. The reaction of one equivalent of DEPC with one 
equivalent of imidazole would result in a mass difference of +72 Da according to Fig. 6.2 
A. The significant modified species had mass differences of +144 (Mr=29558); +216 
(M r=29630); +288 (Mr=29702); +360 (Mr=29774); +432 (Mr=29846) and +504 
(Mr=29918) Da relating to enzyme species with two to seven modified histidine residues 
respectively. These data also show that extensive di-substitution of the imidazole group had 
not taken place.
Although the protected sample was 65% active only a small amount of the 
unmodified enzyme remained (29414 Da)(Fig. 6.8 B). Significant modified species had 
mass differences of +72 (Mr=29486); +144 (Mr=29558); +216 (Mr=29630); +288 
(Mr=29702) and +360 (Mr=29774) Da relating to the modification of one to five histidine 
residues respectively. Accordingly, the occupancy of the active site by shikimate and 
NADP+ has protected two histidine residues from DEPC modification. Thus the possibility 
exists, that these two histidine residues are located at the active site and their identification 
would contribute towards the characterisation of the active site of E. coli SKDH.
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Fig, 6.8 Stoichiometry of incorporation of DEPC into SKDH by ESMS
A. ESMS profile of DEPC modified SKDH (>70% inactivated) in the absence of 
shikimate and NADP+ showed a number of modified species with mass differences of 
+144; +216; +288; +360; +432 and +504 Da indicative of enzyme species with two to 
seven modified histidine residues respectively.
B ESMS profile of DEPC modified SKDH (65% active) in the presence of shikimate and 
NADP+ showed a minor peak corresponding to unmodified enzyme (29414 Da) and five 
modified species with mass differences of +72; +144; +216; +288 and +360 Da relating 
to enzyme species with one to five modified histidine residues. Accordingly, two residues 
are protected by shikimate and NADP+ from DEPC modification.
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6.3 Differential peptide mapping of DEPC modified SKDH by RP-HPLC
In order to identify the two protected histidine residues the technique of 
differential peptide mapping was employed, also successfully used by Vangrysperre et al. 
(1989) and Deka et a l (1992) to study the DEPC mediated inactivation of Streptomyces 
violaceoruber D-xylose isomerase and E. coli type I dehydroquinase respectively. This 
method relies on the fact that A^’-carbethoxyhistidine is sufficiently stable around neutral pH 
(Melchior and Fahmey, 1970) to permit non radioactive DEPC to be used, and labelled 
peptides are simply detected by their absorbance at 240 nm.
DEPC modified SKDH in the absence and presence of shikimate and 
NADP+ (aliquots from the samples prepared in section 3.8.6) were digested using 
subtilisin following dénaturation in 4M GdnHCl. After 2 hours of digestion complete 
digests were obtained which were then fractionated by reverse phase HPLC as described in 
section 3.8.9 using a solvent system maintained at pH 6.4, Comparison of peptide maps at 
240 nm (Fig. 6.9 A-B) resulted in the identification of three peptides which were protected 
by shikimate and NADP+. All three peptides were located in the hydrophobic region of the 
peptide map and had retention times of 39.3 min, 43.9 min and 48.0 min. Since DEPC is a 
hydrophobic reagent carbethoxylated peptides are more hydrophobic than their unmodified 
counterparts and this hydrophobicity shift results in an increase the retention time of the 
modified peptides (Biscoglio et a/., 1986). These differences in the peptide maps were 
highly reproducible between separate experiments unlike the other regions where 
differences were less pronounced and irreproducible.
6.4 Amino-acid sequencing of the isolated peptides
The peptides eluting at 39.3 min, 43.9 min and 48.0 min (referred to as P,Q 
and R respectively) were collected and subjected to Edman degradation. However, no 
sequence was obtained for peptide Q since it comprised of a mixture of peptides, and 
unambiguous sequence determination was not possible. The amino-acid sequences of 
peptide P and R are summarised in Tables 6.2 and 6.3 respectively.
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Fig. 6.9 Differential peptide mapping by RP-HPLC
HPLC profiles of subtilitic digests of DEPC modified SKDH in the absence (A) and 
presence (B) of shikimate and NADP+
Peptide maps were monitored at 214 nm, the common wave length for peptide detection 
and at 240 nm for the detection of peptides with A-carbethoxyhistidines. In the presence 
of shikimate and NADP+ three peptides are protected from carbéthoxylation. They are 
designated as P+, Q+ and R+ in profile (A) and as P-, Q- and R- in profile (B). mAbs 
represents milli absorbance units.
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Table 6.2 
Amino acid sequence of peptide P
Cycle number Residue Yield (pmoles)
1 Ala 50
2 Val 45
3 Phe 33
4 Gly 13
5 Asn 4
6 Pro 8
7 He 6
8 Ala 3
9 ?
10 ?
This sequence is incomplete and represents only a part of the full length of 
peptide P. The isolated peptide had to be further purified by a second HPLC run prior to 
sequencing. As a result very little material was available for sequencing, and because of the 
relatively poor sequencing yield at step 4 only eight cycles in the sequencer was possible.
The above sequence does not contain any histidine residues or any other 
residue that is likely to react with DEPC. However, the residue following the above 
sequence is a histidine and of the eight histidine residues in the E. coli sequence, this 
histidine is the most conserved. The above sequence is followed by a highly conserved 
stretch of residues shown in boldfaces below.
5 A V F G N P I A H S K S P l 7
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It is evident from these data that His-13 is the site of DEPC modification in peptide P. 
Thus, His-13 appears to be the essential histidine responsible for the DEPC mediated 
inactivation of SKDH.
Table 6.3 
Amino-acid sequence of peptide R
Cycle Number Residue Yield (pmoles)
1 Leu 27
2 Leu 19
3 Trp 10
4 His 13
5 Gly 16
6 Val 11
7 Leu 10
8 Pro 6
9 Asp 3
10 Val 1.7
11 Glu 4
12 Pro 3
13 Val 4
14 He 3
15 Lys 1
16 Gin 1
17 --- ---
18 ---
19 --- ---
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The complete peptide R contained 16 amino acid residues and corresponds 
to residues 250-265 in the deduced amino acid sequence of E. c o li. The only histidine 
residue within this peptide is His-253 and this must be the site of DEPC modification in 
peptide R, His-253 is not a conserved residue and is therefore unlikely to be a catalytically 
important active site residue. It's protection by substrate and coenzyme from DEPC 
modification could be simply due to it's presence in the active site region.
6.5 Active site homology
The above work led to the identification of the essential histidine residue as 
His-13. Alignment of the amino-acid sequence surrounding this residue with matching 
regions of other known SKDH enzymes show that it is a conserved region and His-13 is 
conserved in all but one sequence. In A, nidulans this position is occupied by a Gin 
residue. However the A. nidulans sequence has been subjected to many corrections since 
it's initial sequencing and a definitive confirmation of this region in the sequence is needed. 
It shall be noted that a single base change (A/G to C/U) would change the Gin in the A. 
nidulans sequence to a His. The sequence alignments are shown in Fig. 6.10.
6.6 The role of His-13
As described in section 6 .1 histidine residues function in the proton transfer 
step in many pyridine nucleotide dependent dehydrogenases. On the basis of the work 
presented above His-13 is proposed to have this role in SKDH.
Besides chemical modification the study of the pH-dependence of enzyme- 
catalysed reactions can provide information about the nature of the amino-acid side chains 
that participate in catalysis. Because of the proposed role for His-13 in SKDH it will be 
expected that the activity of the enzyme would vary with the ionisation state of His-13. 
Histidines typically have pK& values in the range of 6.0-7.5 and so the pH dependence of 
the oxidation of shikimate by SKDH was investigated over the pH range 5.5-10.8.
In this investigation, the Vmax value at each pH studied was determined by 
varying the concentration of shikimate while keeping the concentration of NADP+
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constant. A plot of pH against log Vmax is shown in Fig. 6.11. Extrapolation of the linear 
portions of the plot yielded a pKa value of 7.3 at the point of intersection which is constant 
with a histidine side chain being involved in the catalytic mechanism. The pKa of the group 
reacting with DEPC was determined to be 6.6 (section 6.2.6), and although these values 
are slightly different they are within range of pKa values for imidazole side groups of 
histidine residues (Lundblad and Noyes, 1984).
These data together with the chemical modification data identifying of His- 
13 as the essential histidine residue, provide strong evidence to confirm the initial proposal 
that a histidine residue functions as a general acid/base in the catalytic mechanism of 
SKDH.
6.7 Discussion
Chemical modification of SKDH by DEPC at pH 7.0 resulted in time 
dependent inactivation of the enzyme and analysis of kinetic data revealed that the 
inactivation was due to the modification of one essential histidine residue. The rate constant 
for the inactivation process was calculated to be 154 M'^ wim-l. This value is higher than 
values frequently found for essential histidines in proteins (Lundblad and Noyes, 1984; 
Church et a l, 1985) and suggested that the essential histidine reacting with DEPC was 
highly reactive. In addition to histidines DEPC can also react with tyrosines, cysteines and 
lysines (Miles, 1977; Lundblad and Noyes, 1984). To investigate whether there were any 
side reactions of this kind difference spectra of DEPC modified SKDH were recorded. 
These showed an absorption maximum at 240 nm typical of V-carbethoxyhistidine (Miles, 
1977). Carbéthoxylation paralleled inactivation and activity was partially recovered 
following hydroxylamine treatment. The possibility of tyrosines reacting with DEPC was 
ruled out since there was no decrease in difference spectra at 278 nm (Burstein et al, 1974; 
Miles, 1977). There are three cysteine residues in the primary sequence of SKDH and 
reaction with 5,5'-dithiobis(2-nitrobenzoate) (Ellman, 1959) in the presence and absence of 
0 .1% sodium dodecyl sulphate showed that two of these residues are in a buried 
conformation and only one sulfhydryl group is exposed in the native protein. However,
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Fig. 6.11 pH dependence of the SKDH catalysed reaction
Extrapolation of the linear portions of the plot of pH against log Vmax intersect at pH 7.3 
indicating that a group with a pKa of 7.3 is involved in the catalytic reaction.
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incubation of SKDH with cysteine specific reagent V-ethylmaleimide (Lundblad and 
Noyes, 1984) did not inactivate the enzyme even at high reagent concentrations, indicating 
the absence of any active site sulfhydryl groups. Therefore any contribution towards DEPC 
inactivation of SKDH by a modified cysteine was very unlikely. The reaction of reactive 
lysines with DEPC is reported to have very low rates ( Wells, 1973; Church et a i, 1985) 
and a second-order rate constant of 154 M"  ^ is much too high for a typical lysine 
residue. The pH dependence of inactivation demonstrated that the inactivation was due to 
the modification of a group with a pKa of 6.6 which was also consistent with the essential 
residue modified by DEPC being a histidine residue.
Complete inactivation of the enzyme correlated with the modification of 
approximately seven histidine residues, calculated from the molar absorption difference for 
V-carbethoxyhistidine (Ae240=3200 M 'l cm-^; Miles, 1977). This number is in good 
agreement with the ESMS data where the maximum stoichiometry of incorporation in an 
extensively modified sample (>70% inactivated) was determined to be seven. In the 
protected sample only five histidines were modified as revealed by ESMS and therefore 
two histidines were inaccessible to DEPC in the presence of shikimate and NADP+.
Attempts to identify the sites of DEPC modification by LCMS were 
unsuccessful. The most widely used buffer system for the fractionation of DEPC modified 
peptides is sodium/pota|ium phosphate at neutral pH (Vangrysperre et ai, 1989; Deka et 
a l,  1992). Since LCMS operates on volatile buffers these buffers could not be used, 
alternatively a phosphoric acid based buffer system at pH 4.5 was employed. LCMS of a 
chymotryptic digest of DEPC modified SKDH resulted in the identification of two modified 
histidine residue; His-164/179 and His-253. The limited stability of the carbethoxylated 
histidine residues of proteins is a main problem encountered in their identification 
(Holbrook and Ingram, 1973; Burstein et aL, 1974). Therefore, failure to identify other 
modified histidine residues by LCMS can be attributed to the instability of the 
carbethoxyhistidine residues at pH 4.5. However, cases have been reported where N~ 
carbethoxyhistidines had been sufficiently stable around neutral pH to permit their isolation 
(Vangrysperre et aL, 1989; Deka et aL, 1992). Hence, the alternative approach of
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differential peptide mapping using sodium phosphate buffer, pH 6.4 was employed to 
identify the peptides containing the two protected histidine residues.
Sequencing of the substrate protected peptides identified His-13 and His- 
253 as the two protected histidine residues. His-253 is not a conserved residue and it’s 
protection by substrate may simply reflect it's presence in the active site region. His-13 is a 
highly conserved residue and appears to be the essential histidine responsible for the DEPC 
mediated inactivation of SKDH. The pH-dependence of the enzyme catalysed reaction 
implicated the involvement of a histidine residue in the catalytic mechanism. Based on a 
general mechanism for the bond forming events of pyridine nucleotide dependent 
dehydrogenases (Bloxham et a l, 1975), a reaction scheme involving His-13 for the 
conversion of 3-dehydroshikimate to shikimate by SKDH can be proposed as shown in 
Fig. 6.12. Full confirmation of this role for His-13 must await site-directed mutagenesis 
and eventually three dimensional structure determination.
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Fig. 6. 12 The proposed reaction scheme for SKDH involving His-13 as a 
general acid/base
The substrate (3-dehytiroshikimate) is activated by a hydrogen bond formation between 
substrate carbonyl and protonated form of His-13 (for the forward reaction). This polarises 
the substrate carbonyl group and facilitates hydride transfer from NADPH after which 
complete protonation of the carbonyl group occurs. Similarly, in the reverse reaction the 
hydroxyl hydrogen of shikimate forms a bond with the unprotonated form of His-13 
facilitating hydride removal.
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CHAPTER 7
General discussion and future prospects
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7.1 The active-site of E. coUSKDH
The preceding chapters have described in detail the progress made towards 
the characterisation of the active-site of Kcoli SKDH. It has been shown that;
(I) Lys-65 mediates the binding of shikimic acid via an interaction 
between it's e-amino group and the carboxyl group of shikimate.
(II) Arg-154 is a component of the NADP+ binding site, and interacts 
with the 2 ' phosphate group of the adenosine moiety.
probably(in) His-13 is^involved in proton transfer as a general acid/base 
^  facilitating substrate reduction/oxidation.
Thus, these findings can be summarised in a schematic model of the proposed active-site of 
E. coli SKDH as shown below (Fig. 7.1).
NH
zNHg
N
OHHis
OH
Fig. 7.1 Schematic model of the proposed active-site of E. coli SKDH containing the residues identified in this project.
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7.2 Structural and mechanistic features of E. coli SKDH
In the absence of the crystal structure chemical modification studies together 
with sequence data can give useful information about the structural and mechanistic features 
of an enzyme molecule. SKDH is monomeric in structure, and contains 272 amino-acid 
residues in the sequence. Alignment of all known amino-acid sequences of SKDH from 
various organisms (see appendix) shows that most of the conserved residues are located in 
the N-terminal region of the polypeptide chain. The identification of His-13 and Lys-65 as 
residues involved in catalysis and substrate binding respectively, suggest that this region of 
the polypeptide chain is involved in substrate binding and catalysis. Furthermore, the 
presence of Lys-15 in this region and it’s proximity to His-13 explains the partial nature of 
protection afforded by substrate and coenzyme against TNBS modification. In the case of 
His-253, which from the protection studies must be at or near the active-site, could be 
present on a loop of the polypeptide chain which in the folded structure comes close to the 
active-site.
The 'fingerprint' characteristic of the ADP binding |3ap fold lies between 
residues 121 and 151 (Anton and Coggins, 1988). The a  helix dipole of this fold is known 
to interact with the pyrophosphate group of the coenzyme and facilitate it's binding. In 
enzymes that bind NADP+ by this fold, the final position of this fingerprint should not be a 
negatively charged residue in order accommodate the 2 ' phosphate group of the adenosine 
moiety (Wierenga et a l, 1986), and a positively charged side chain nearby would provide a 
binding site for the adenosine phosphate (Branden and Tooze, 1991). Thus in SKDH 
which is NADP+ specific, the final position of the fingerprint is occupied by Thr-151 and 
two residues further in the sequence is Arg-154, which was identified as the residue 
interacting with the 2’ phosphate group of NADP+. Similar situations are encountered in 
other NADP+ specific enzymes; for example in the E. coli glutathione reductase the final 
position in the fingerprint is occupied by Val-197 and Arg-198 is involved in binding the 
adenosine phosphate (Scrutton et a l, 1990).
Many dehydrogenases follow a compulsory order mechanism, where the 
enzyme complexes with the coenzyme to form a binary complex which then forms a ternary
1 2 5
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complex with the substrate. In protection experiments against TNBS and DEPC 
inactivation shikimate alone afforded partial protection, which was enhanced in the 
presence of NADP+. This may imply that in the absence of NADP+, shikimate forms a 
weak complex with the enzyme. The binding of the coenzyme at the enzyme surface may 
generate a second binding site for the substrate which did not previously exist (Takenaka 
and Schwert, 1955). Thus, the possibility exists, that shikimate binds at two sites one of 
which is generated by the binding of NADP+. Alternatively, the binding of the coenzyme 
may alter the affinity of the pre-existing substrate binding site. Therefore, it appears that the 
proper binding of shikimate is facilitated only in the presence of the coenzyme. Moreover, 
product inhibition and isotope exchange studies on P. sativum SKDH have shown that it 
functions through an ordered mechanism (Balinsky et al., 1971). In the protection 
experiments mentioned above, NADP+ alone afforded significant protection although Lys- 
65 and His-13 are residues involved in shikimate binding and catalysis. Therefore, it is 
possible that binding of NADP+ induces a conformational change in the protein molecule 
and this may also support the notion that a second binding site for shikimate is generated 
upon NADP+ binding. Alternatively, the protection afforded by NADP+ against TNBS 
and DEPC inactivation could be simply due to steric hindrance in the active site pocket.
7.3 Future prospects
As a part of a complete structural and mechanistic study of E. coli SKDH, 
the main objective of the project was to study the active-site. In fulfilling this objective, 
three active-site residues have been identified and a knowledge of how SKDH converts 3- 
dehydroshikiraate to shikimate has been obtained. This work should be followed by site- 
directed mutagenesis of the identified residues, to confirm their roles in the mechanism.
On the mechanistic side, the next step would be to determine the binding 
order of the mechanism and to measure substrate binding constants. The first of these could 
be done by product inhibition studies while the second would require equilibrium dialysis 
or microcalorimetry. The main limitation in doing product inhibition studies is the non­
availability of the natural substrate, 3-dehydroshikimate. This compound is not stable
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enough to be stored over a period of time and has to be synthesised from 3~dehydroquinate 
immediately before use. Equilibrium dialysis require radio labelled reagents which are also 
not readily available. Therefore, microcalorimetry would be the preferred method to study 
the ligand binding in the case of SKDH.
Having obtained a knowledge of the active site structure and the catalytic 
mechanism, the next step would be to determine the three dimensional structure of SKDH. 
The first prerequisite for solving the three dimensional structure by X-ray crystallography 
is a well-ordered crystal that will diffract X-rays strongly. Crystal growth depends on 
many parameters such as pH, protein concentration, nature of solvent and precipitant and 
the presence of added ions or ligands. Therefore, in a preliminary experiment all these 
parameters were screened and the optimal conditions for the crystallisation of SKDH were 
determined. Microcrystals of SKDH were obtained by the sitting drop method, in 5 mg/ml 
protein concentration and a precipitant solution containing 18-20% ammonium sulphate in 
50 mM bis-tris/HCl buffer pH 6.0-6.2. This experiment was repeated using identical 
conditions except that 2% PEG-600 was added to the precipitant solution. This resulted in 
slow growth and improved the size of the crystals, which are shown in Fig. 7.2. Thus, the 
combination of parameters suitable for the crystallisation of SKDH has been established. 
The next step, will be to obtain larger crystals which can diffract X-rays, hopefully by 
refinement of the conditions mentioned above.
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Fig 7.2 Crystals of E. coli SKDH formed by the sitting-drop method
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Appendix
eco ...MET..YA pae ...MDR..YC Bac MCKLEKFNYA psa QLGPETKVYG nta QLGPDTRIFG see MGGIEPKELFani  PKKFApea MGLLPEKKYF Cons  e. . .Y
VFGNPIAHSK VFGNPIGHSK LFGNPIDHSQ IIGKPVSHSK IIGKPVSHSK WGKPIGHSR IFGSPISQSR LFGKPIKHSQ ..G.Pi.HS.
SPFIHQQFAQ SPLIHRLFAE SPKIHNFFAT SPILFNEAFK SPLLYNEAFR SPILHNTGYE SPALHNTLFA SPNIHNLGFE SP..hN___
QLNIEHPYGR QTGEALVYDA QTGILHIYKA TVGFNGVFVF SVGFNGVYMP ILGLPHKFDK QVGLPHNYTR ILGLPYKYQL 
. . g  y . .
VLAPINDFIN45QLAPLDDFPGINIPLDQFSSLLVDDLANFLLLVDDVANFFFETESAQLVKLETTNAQDVQFETDSISELK
eco TLNAFFSAGG pae FARRFF.EQG Bae WSDFFKKNI psa RTY..SSTDF nta RTY..SSLDF see EKLLDGNKNF ani E..FIRSPDF pea EILHLE..EF Cons .........
KGANVTVPFK KGANVTVPFK KGANVTAPFK VGFSVTIPHK AGSAVTIPHK GGAAVTIPLK GGGSVTINLK GGASVTIPLK ,G..Vtip.K
EEAFARADEL EEAYRLVDEL KEAYFFSDKL ESALKCCDEV EAIVDCCDEL LDIMQYMDEL LDIMPLLDEV TNISILLDEI ....... De.
TERAALAGAV SERATRAGAV TERAKIAQSV DPVAKSIGAV NPTAKVIGAV TDAAKVIGAV AAFAFIIGAV SDHAALIGSV ...A ...gaV
NTLMRLEDGR195NTLIRLADGRNTLKKISDKCN ........NCWSRLDGK NTVIPLGNKK NTIIPVSTGK NTITR..TYN Nt.......
eco  LLGDNpae .....LRGDNBac  ILGDNpsa .........n t a  LFGCNsee  FKGDNani NTPSRLVGRN pea NGQYILKGEN Cons  l.G.N
TDGVGLLSDL .ERLSFIRPG LR......  ILLIGAGGASiaiTDGAGLLRDL TANAGVDVRG KR. . .   VLLLGAGGAVTDGIGLLSDL V.RLNFIKKN FS.......  ILILGAGGAV
TDYVGAISAI EEALQGSQPS MSGSPLAGKL FWIGAGGAG TDWLGIRNAL INNGV...PE YVGHTAG... .LVIGAGGTS TDWQGMILSL RKAGVYGPKR KDQEQSA. . , .LWGGGGTA TDWQGIIKAI KNFNKFE..K SFENFSG... .FIIGAGGAS TD ..G.....  ....... . .1.. GaGG. .
eco RGVLLPLLSL DCA.VTITNR TVSRAEELAK LFAHTGSIQA LSMDE 175pae RGVLEPFLGE CPAELLIANR TARKAVDLAE RFADLGAVHG CGFAE....Bac KGVLLPLLSL GCS.VYILNR TILNAKILVK QFNKYGKIFV FDRQN....p s a .......................... ...........................nta KALAYGAKEK GARWI......................ANRT YERARELADVsee RAALYALHSL GCKKIFIINR TTSKLKPLIE SLPSEFNIIG lESTKSIEEIani RAAIYALHNM GYSPIYIVGR TPSKLENMVS TFPSSYNIRI VESPSSFESVpea RAAIYALLSL GISPIYLINR SKDKLNKLYH FFNTN.HIIP ITEYHELNNICons ..... 1............R ........!.. . f.... i.............
ecopaeBacpsantaseeanipeaCons
LEGHEFDLIIVEGP.FDLIVFKQQNFDLVI
NATSSGISGD IPAIPSSLIH PG.I.............YC210NGTSASLAGD VPPLAQSVIE PGRT.............VCNAMSRNTEKK NFTL...ILI TSKR.............FF
VGGQALSLDE KEHVGVAVSC PH...VAIGT NFDIRIGIST
LSNFHPENDM ILANTTSIGM QPKVDDTPIF KEALRYYSLVVPADKPLDDE LLSKLERFLV KGAHAA..........FVPTLIPADQPIDPT MRETLCHMFE RAQEADAEAV KAIEHAPRIL IPTDNPIDPS VLEIAKIFFN LKRKSSEG...........IF
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eco YDMFYQKGKT PFLAWCEQRG SKRNADGLGM LVAQAAHAFL LWHGVLPDVE2 6 0pae YDMMYAKEPT AFNRWAAERG AARTLDGLGM LVEQAAEAFF LWRGVRPASABac YDMNYSTRNT PFINWCSKAG GSFISNGIGM LVFQAAYSFL EWHNVLPEINp s a ......................................................nta FDAVYTPKIT RLLREAHES. GVKIVTGVEM FIGQAYEQYE RFTGLASSKGsee LEAAYKPSVT PVMTISQDKY QWHWPGSOM LVHQGVAQFE KWTGFKGPFKani LEMAYKPQVT ALMRLASDS. GWKTÏPGLEV LVGQGWYQFK YWTGISPLYEpea LDMAYGSNTT D.LTIIAKAC NWKIIHGLEI LLEQGSEQFL LWTETYIPYNCons .D..Y....T................. G... lv.Q....f. .w........
eeo PVÏKQLQEEL SA 272 .........................................................................................................pae PVLETLRRQL ATV*.......................................Bae YIINILNIK* ................. .........................p s a ........... ........................................nta TFQENYGWIL RARSLSLFNA ALLVTFPPKS LHSCVIAMVL DSSALPFVLRsee AÎFDAVTKE.............................................ani SARACSSPLI ...........................................pea QVKYAILGPN K..........................................Cons ............ .........................................
eeo .. pae . , Bae .. psa ,. nta RN see . . ani . . pea . .Cons ..
Alignment of SKDH sequences taken from the GCG PileUp program {Devereux et a l * r 1987) mounted on the Glasgow University UNIX system. References; E, c o l i  {Anton and Coggins, 1988), 
Pseudomonas  a e r u g i n o s a (accession no. X85015), Buchnera  
a p h i d i c o l a  (accession no. U09230), Pisum s a t i v u m  (Deka et ai., 1994), N i c o t i a n a  tabacum (Bonner and Jensen, 1994), 
S a c c h a r o m y c e s  c e r e v i s i a e  (Duncan et ai,, 1987), A s p e r g i l l u s  
n i d u l a n s  { C h a r l e s  e t  ai., 1986; J. Moore and A.R. Hawkins, personal communication) and P n e u m o c y s t i s  c a r i n i i  (Banerji et ai., 1993).
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